Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.7977647121362246,2.5603656812103583,0.0,0.0,0.0,16/29,9.50%,GRID2;GRIK5;GRIK2;GRID1;GLRA3;GABRG3;GABRB1;GRIA4;GABRB3;HTR3A;GABRB2;GABRA2;GRIK1;GRIA2;GABRA3;GABRA1
prerank,ligand-gated channel activity (GO:0022834),0.760261620429764,2.47415244971291,0.0,0.0,0.0,12/29,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ligand-gated ion channel activity (GO:0015276),0.7567097293969319,2.4679194839220204,0.0,0.0,0.0,12/30,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,voltage-gated cation channel activity (GO:0022843),0.5999106227120686,2.4305012688056813,0.0,0.0,0.0,39/97,15.02%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;GRIN2B;KCNA6;KCNH8;KCNQ5;KCNH7;OPRM1;KCNA5;CACNA1B;CATSPER4;CACNA2D1;KCNH4;GRIN2A;KCNH5;CACNA1A;KCNA2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;KCND1;CACNG5;GRIN3A;CACNA2D4;KCNS2;KCNC4;KCNA4
prerank,glutamate receptor activity (GO:0008066),0.8542279691395636,2.4012472655049484,0.0,0.0,0.0,12/19,8.89%,GRID2;GRM5;GRIK5;GRIK2;GRID1;GRIA4;GRM8;GRIA1;GRM1;GRIK1;GRIA2;GRM7
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7935035634848298,2.258006123228028,0.0,0.00029288283815446793,0.002,9/17,8.83%,GRIA3;GRIK5;GRIK2;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7536109856344535,2.1930711512968757,0.0,0.0002510424327038296,0.002,9/19,9.50%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,ligand-gated anion channel activity (GO:0099095),0.7806530545294849,2.1825703720421696,0.0,0.00021966212861585096,0.002,9/17,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;GLRA1;GABRB2;GABRA2;GABRA3;GABRA1
prerank,potassium channel activity (GO:0005267),0.5441718814258084,2.18075052259824,0.0,0.00019525522543631198,0.002,16/89,4.61%,KCND2;KCNC2;KCNQ3;GRIK5;GRIK2;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNH4;KCNH5;KCNN2;KCNA2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6802516182506968,2.179655419387256,0.0,0.00017572970289268076,0.002,9/28,9.50%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,GABA receptor activity (GO:0016917),0.7164294120727258,2.12087849869288,0.0,0.000319508550713965,0.004,10/21,14.23%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABBR2;GABRA3;GABRA1;GABBR1;GABRE
prerank,voltage-gated potassium channel activity (GO:0005249),0.5431383692227079,2.1171363926251012,0.0,0.00036610354769308495,0.005,15/80,4.61%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;KCNH5;KCNN2;KCNA2
prerank,GABA-A receptor activity (GO:0004890),0.7240200480128138,2.0526277597578653,0.0,0.002703533890656627,0.038,7/18,9.50%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,neuropeptide receptor activity (GO:0008188),0.6320436704192859,2.0395596181041276,0.0022988505747126436,0.003451833449677658,0.052,9/29,11.23%,NPSR1;OPRM1;SORCS1;SORCS3;GPR37;NPY2R;KISS1R;TACR1;NMUR2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.776563035933721,2.01430375983157,0.0,0.004393242572317019,0.068,7/12,9.50%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5843954452059223,1.994672635023329,0.0,0.005930877472627976,0.096,22/37,17.93%,OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;CACNG5;CACNA2D4;CACNB1;CACNA1G;CACNA1I
prerank,cadherin binding (GO:0045296),-0.42289384811915554,-1.9578888296859,0.0,0.08772294516276556,0.078,116/315,18.00%,PTPRB;SPTBN1;CLINT1;TJP1;DAB2IP;DOCK9;PTPRM;ESYT2;CTNNA1;ITGA6;SPTAN1;WASF2;CAST;COBLL1;LIMA1;ITGB1;BSG;MRTFB;ASAP1;ERC1;STXBP6;ABI1;BAIAP2L1;MPP7;CDH11;MYH9;CD2AP;PPFIBP1;BMPR2;PARVA;EPS15;IQGAP1;EIF4H;ANXA2;PROM1;PTPN1;TRIM25;F11R;ZC3HAV1;PKP4;FNBP1L;PAK2;EIF3E;DDX3X;RAB1A;AHNAK;KDR;YWHAE;PTPRJ;EGFR;GIGYF2;NOTCH3;EMD;EPS8L2;IDH1;PDLIM5;LARP1;CBL;PLCB3;AFDN;NCK1;DLG1;STK24;TRPC4;TMOD3;MACF1;EPS15L1;EZR;SNX9;CDH5;TJP2;MRE11;FXYD5;PDLIM1;CTNND1;CEMIP2;YWHAZ;CDH1;PICALM;CHMP4B;FLNA;PUF60;SERBP1;ARHGAP1;EHD1;PSEN1;EEF2;STK38;LASP1;LRRFIP1;CSNK1D;NDRG1;CHMP2B;PDXDC1;PKN2;RPL7A;NUMB;HCFC1;MARK2;SH3GL1;CLIC1;FMNL2;ABCF3;EHD4;CHMP5;SLK;GCN1;ANXA1;CTNNB1;SWAP70;CALD1;DBNL;VAPA;CAPZB;GIPC1;CCS
prerank,sodium channel activity (GO:0005272),0.5725118555788451,1.9555672005362041,0.0,0.008838170351367181,0.136,11/37,8.20%,GRIK5;GRIK2;ASIC2;HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;GRIK1;SCN5A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5861479389983426,1.9288068258580422,0.0,0.011373616881665173,0.186,6/32,4.61%,KCNC2;KCNQ3;KCNA6;KCNQ5;KCNA5;KCNA2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7276499744509515,1.906774056252408,0.011185682326621925,0.014289599524694304,0.241,7/13,14.23%,GLRA3;GABRG3;GLRA1;GABRA2;GABRA3;GABRA1;GABRE
prerank,clathrin adaptor activity (GO:0035615),-0.7333592882899913,-1.8965639946688713,0.0,0.11732943915519893,0.184,11/15,20.03%,HIP1;DAB2;STON1;LDLRAP1;AP2B1;AP2A2;AP2S1;AP1G1;HIP1R;STON2;AP2M1
prerank,ligand-gated cation channel activity (GO:0099094),0.4738077452236681,1.851527888879436,0.0,0.026886644542580152,0.403,19/75,14.59%,GRIA3;GRIK5;GRIK2;ASIC2;GRIN2B;GRIA4;HTR3A;KCNJ3;GRIN2A;KCNN2;GRIA1;GRIK1;KCNJ6;GRIA2;KCNN3;P2RX3;GRIN3A;P2RX5;ASIC1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5614659660782151,-1.8390730553408456,0.0,0.15717027674995498,0.337,16/34,22.11%,CYTH3;PARD3;MYO10;FERMT2;IQGAP1;ARAP3;AKT1;ARAP1;FCHSD2;ZFYVE1;HIP1R;GAB2;ZFYVE16;OGT;PHLDA3;KIF16B
prerank,ion channel activity (GO:0005216),0.4623507817282112,1.837570361509813,0.0,0.030710857600768495,0.463,17/80,8.83%,TRPM3;GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;UNC80;GRIA4;GRIN2A;GRIA1;TMC1;TMEM63A;GRIK1;TRPM1;GRIA2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6381750503444733,-1.8093407394063448,0.0,0.16804426682742277,0.429,9/18,15.62%,ENG;FERMT2;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD7;USP15;SMAD6
prerank,cell adhesion mediator activity (GO:0098631),0.5885057948264732,1.8017124739529906,0.0022988505747126436,0.044411688549241136,0.612,14/24,15.73%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2;JAM3;ROBO3;CD47;SIRPA
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.650246391661496,-1.7991491122647378,0.005208333333333333,0.15263792458321207,0.474,4/17,1.27%,ATP10A;PITPNC1;ATP8B1;PLTP
prerank,I-SMAD binding (GO:0070411),-0.6898421555683126,-1.7664802255930534,0.0,0.19317323549384,0.626,8/13,19.65%,SMURF1;SMAD1;SMAD2;SMAD4;SMAD7;SMAD6;CTNNB1;SMAD9
prerank,chloride channel activity (GO:0005254),0.47135729654082104,1.7401201392645476,0.00468384074941452,0.07797050513129597,0.824,13/59,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;GABRA3;GABRA1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.40649123934868775,-1.739629146332599,0.0,0.22745306495774212,0.731,56/147,21.47%,RAPGEF5;PREX2;CYTH3;DOCK9;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RIN3;FGD6;RAB3GAP1;RCBTB2;ARHGEF28;DOCK4;ELMO1;FARP1;EPS8L2;RASGRF2;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;PLCE1;ITSN1;DENND3;SH3BP5L;RASGRP2;ARHGEF2;DENND6A;EIF2B2;RAB3GAP2;RAPGEF1;IQSEC2;ARHGEF11;ARFGEF1;RIN2;ARHGEF10;DENND4C;DENND2C;ABR;ARHGEF18;HERC2;PREX1;ALS2;ANKRD27;RGL1;WDR41;RGL2;SPATA13;ARHGEF5;NUCB2;RABIF;VAV2
prerank,retinoic acid receptor binding (GO:0042974),-0.6367708438351029,-1.737772558441687,0.0017761989342806395,0.2039558475034299,0.736,9/17,20.11%,TACC1;NSD1;ASXL1;NRIP1;RARG;MED1;ACTN4;NCOA6;PPARG
prerank,tau-protein kinase activity (GO:0050321),-0.6035715311366171,-1.7336034143356098,0.00749063670411985,0.1897008689144805,0.747,11/20,16.69%,DYRK1A;GSK3B;MARK1;ROCK1;GSK3A;SIK3;PRKAA1;MARK2;ROCK2;FYN;MARK3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.629621021579524,-1.7206850593572698,0.007312614259597806,0.19748628029767598,0.786,9/18,23.64%,STXBP6;BAIAP2L1;ANXA2;PDLIM5;TMOD3;PDLIM1;ANXA1;CDC42EP1;PPP1CA
prerank,androgen receptor binding (GO:0050681),-0.5765017933385767,-1.7195377111307317,0.0,0.1814270002229924,0.79,6/25,10.80%,FOXP1;NSD1;ZBTB7A;PRPF6;WIPI1;KDM3A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7093269571684371,1.7104032513514824,0.018779342723004695,0.09859168539374777,0.897,6/10,18.60%,GABRG3;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6818736272593391,1.7092527515682379,0.01098901098901099,0.09563210431419687,0.9,4/11,9.14%,DDAH2;PADI1;ARG2;PADI2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7140681015997734,1.7082069336320624,0.00646551724137931,0.09262982992862268,0.9,5/10,7.76%,CACNA1B;CACNA1A;CACNB3;CACNA1D;CACNB4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.499076188455843,-1.704365628518587,0.0017301038062283738,0.1965542240053216,0.841,19/44,15.61%,MECOM;NSD1;ASH1L;SETD2;PRDM16;KMT2E;KMT5B;NSD3;SETD5;SUV39H1;SETD3;EHMT1;DOT1L;ASH2L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C
prerank,thyroid hormone receptor binding (GO:0046966),-0.551348619782543,-1.6949346035085613,0.005555555555555556,0.2035341025747628,0.867,16/28,29.30%,TACC1;NSD1;MED1;TRIP12;TAF11;MED13;JMJD1C;MED17;HMGN3;TAF7;NCOA6;ZNHIT3;THRAP3;GAS2L1;OASL;BRD8
prerank,GTPase activator activity (GO:0005096),-0.3638270283880602,-1.6942570762455322,0.0,0.19064075761265298,0.87,113/313,22.62%,RAPGEF5;PREX2;CYTH3;DOCK9;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RGS3;RIN3;ASAP1;RALGAPA1;FGD6;RAB3GAP1;RCBTB2;RGS5;ARHGEF28;STARD8;IQGAP1;DOCK4;RALBP1;ARHGAP10;ELMO1;FARP1;LRRK2;ARAP3;EPS8L2;RANBP2;TBC1D1;RASGRF2;CHN1;TBC1D2B;PLCB1;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;TBC1D8B;JUN;PLCE1;ITSN1;USP6NL;SIPA1L3;DENND3;SH3BP5L;RASGRP2;TBC1D30;BNIP2;ARHGEF2;TBC1D14;MTSS2;ARHGAP17;DENND6A;STARD13;EIF2B2;TBC1D22B;RASA4;RAB3GAP2;RAPGEF1;ARAP1;ARHGAP1;IQSEC2;TBC1D22A;ARHGEF11;ARFGEF1;RASA1;RIN2;ARHGAP28;WNT11;ARHGEF10;LARS1;DENND4C;SEC23B;TBC1D20;SMAP2;DENND2C;ARHGAP22;ABR;ARHGEF18;HERC2;PREX1;ALS2;ARHGAP29;ANKRD27;ARHGAP35;TBC1D8;RGL1;TBC1D17;ARHGAP26;TBC1D25;WDR41;RGL2;SPATA13;ARHGAP42;NF1;ARHGEF5;ASAP3;NUCB2;RABIF;VAV2;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARFGEF2;ARHGAP11A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6682056334677277,-1.6913076858040221,0.014705882352941176,0.18392577502459845,0.882,6/12,12.29%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;LTBP4
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3893068511099284,-1.6890665245678533,0.0,0.1773648297509666,0.887,51/173,18.45%,FOXP1;KLF12;FOXP2;ETV6;ZBTB16;ZBTB20;ZEB1;ZFHX3;PRDM5;PRDM16;NFATC4;MITF;NR3C1;ZBTB37;SOX13;PLAGL1;ZNF148;ELK3;CTCF;NFKB1;HES1;PPARA;FOXO3;GTF2IRD1;MAX;SKIL;JUN;ZBTB4;ZFP90;TBX2;DACH1;ZBTB39;PRDM2;PPARD;ZNF25;ETS2;LRRFIP1;ZBTB6;MZF1;ZBTB25;ZBTB34;TCF3;TRPS1;HIC1;SKI;ZNF692;ZBTB14;PATZ1;HEY1;HEY2;ZBTB12
prerank,GTPase binding (GO:0051020),-0.38634349960448366,-1.6888045483587886,0.0,0.16718961313374142,0.888,56/195,15.56%,SPTBN1;UNC13B;GNB1;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;FNBP1L;PAK2;LRRK2;EXOC4;RANBP2;AFDN;RASIP1;STRN3;AMBRA1;HPS4;BNIP3;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;RASA1;ANKFY1;GOLGA4;LCP1;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,calcium:sodium antiporter activity (GO:0005432),0.6896198688659158,1.685581563603247,0.010893246187363835,0.10807376727899866,0.936,6/10,16.03%,SLC24A4;SLC24A2;SLC8A2;SLC8A3;SLC8A1;SLC8B1
prerank,SH3 domain binding (GO:0017124),-0.45744828605049787,-1.6781752687769826,0.0,0.17611599615663556,0.91,16/62,6.07%,AFAP1L1;DAB2IP;WASF2;SHANK3;AFAP1L2;RUFY1;ABI1;CD2AP;ELMO1;CRK;PTPN12;ADAM9;CBL;CNTNAP1;ABL1;DNM2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.621496243406004,1.674836240914725,0.023094688221709007,0.11369084171074685,0.95,5/14,13.80%,SLC7A11;SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,R-SMAD binding (GO:0070412),-0.6022766761828396,-1.6740755661646949,0.009140767824497258,0.17440706597491945,0.923,9/18,21.03%,SMURF1;LDLRAD4;JUN;SMAD2;SMAD4;RGCC;SMAD6;PMEPA1;DROSHA
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.36750942001012166,-1.673282560950932,0.0,0.16711221053506842,0.925,62/254,15.00%,MECOM;LEF1;KLF7;NFIA;RREB1;ZBTB16;NFIB;ERG;FOXO1;MEF2A;NFAT5;ELF1;KLF4;ETS1;ESR1;TCF12;IRF2;PRRX1;NFATC1;PRDM16;FOSL2;ZSCAN21;MITF;NR3C1;PLAGL1;SOX17;SP1;ELK3;NFKB1;PPARA;MEOX2;SIX1;UBP1;FOXO3;STAT6;NFYC;E2F4;MEF2C;JUN;SMAD1;SMAD2;PRDM2;IRF1;SMAD4;GLIS2;TP53;KLF10;NFIC;GMEB1;FOXF2;FOXJ3;CREBRF;PLSCR1;TFCP2L1;SMARCD3;ZIC3;ATF4;MZF1;GRHL1;TCF3;FOXC1;MYBL2
prerank,metallocarboxypeptidase activity (GO:0004181),0.5390699544007693,1.6681615842316768,0.006772009029345372,0.11664816485117603,0.957,9/26,14.22%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,amino acid:sodium symporter activity (GO:0005283),0.6460942723121683,1.6609468138130687,0.021176470588235293,0.11970121595373105,0.966,4/11,13.80%,SLC6A15;SLC6A11;SLC1A2;SLC1A3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6861928847668203,-1.6439983683110708,0.0136986301369863,0.21147495708880984,0.959,6/10,10.19%,MECOM;ASH1L;PRDM16;SETD5;SUV39H1;EHMT1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6570225717073361,-1.63577547483544,0.015901060070671377,0.21811114092742168,0.974,6/11,25.69%,MAP3K20;MAP3K5;EGFR;MAP3K6;MAP3K7;MAP3K15
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3280058446380987,-1.6355729122800915,0.0,0.209009451953024,0.974,179/732,18.46%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;FOXN3;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;TIPARP;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.3268637802993627,-1.6299425751693728,0.0,0.2112660929336604,0.978,179/731,18.46%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;CREB3L2;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,retinoid X receptor binding (GO:0046965),-0.6725425645545309,-1.6285353135475675,0.017421602787456445,0.20549099904377832,0.979,4/11,5.58%,TACC1;NSD1;NRIP1;RARG
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.6814291573754617,-1.6266018471971926,0.03119584055459272,0.20188929735296093,0.98,6/10,8.26%,NSD1;ASH1L;SETD2;NSD3;SETD5;SETD3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.686826604567243,-1.6199018694001934,0.02158273381294964,0.20687994567552212,0.985,4/10,8.86%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.48146305299005887,-1.607408236285946,0.014571948998178506,0.2247508849504962,0.996,18/38,26.64%,HIP1;DAB2IP;PARD3;SH3PXD2B;PLA2G4A;ZFYVE26;TECPR1;WIPI1;SNX12;PLEKHA4;ZFYVE1;WDR45B;PHLDA3;SNX13;KIF16B;ATG2A;PLEKHF1;ATG2B
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3663582722491347,-1.6050413251572562,0.0,0.22123575523592295,0.996,70/188,24.95%,PBX1;SMARCA2;FLI1;ZBTB20;BNC2;KLF4;ETS1;TCF12;PRDM5;RXRA;PRDM16;SOX13;SOX17;PSPC1;SP1;VSX1;CTCF;NFKB1;SIX1;FOXO3;NFYC;GABPB2;CREB3L2;MEF2C;JUN;SUV39H1;YAP1;IRF1;SMAD4;TAL1;GLIS2;TP53;PER3;SOX7;CHD3;HDAC4;SFPQ;GABPB1;ASH2L;ATF4;MZF1;GRHL1;FOXC1;BCOR;PRDM9;SMAD6;TAF7;ARID5B;ZBTB14;TFAP4;CARM1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;NFE2L2;GABPA;RELA;KCNH2;YY1;ATF6;RBBP5;CEBPA;ATF5;TAF9;HMGB1;DHX9
prerank,protein phosphatase 1 binding (GO:0008157),-0.5539953529774058,-1.6013553622809802,0.015985790408525755,0.22058665585720424,0.997,6/21,8.96%,AKAP11;PPP1R3B;SHOC2;PHACTR4;KCNQ1;PPP1R3C
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5422901469843511,1.5953572501339592,0.02522935779816514,0.19386954319128008,0.996,4/19,1.83%,GRM5;NRG3;NRG1;DGKQ
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5667513946606573,-1.591079973347462,0.028622540250447227,0.2328195262344044,0.998,7/18,12.29%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;ACVR2A;LTBP4
prerank,voltage-gated sodium channel activity (GO:0005248),0.5299046064758333,1.5896615552788727,0.020737327188940093,0.1951423435091066,0.998,7/22,8.20%,HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;SCN5A
prerank,vinculin binding (GO:0017166),-0.6523424649308358,-1.5876310182581077,0.02033271719038817,0.23219167047769507,0.998,7/11,23.66%,UTRN;CTNNA1;PXN;ACTN1;SORBS3;RTCB;TLN1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5355314178984546,1.5860106844109858,0.027600849256900213,0.18316055890071412,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5355314178984546,1.5860106844109858,0.027600849256900213,0.18316055890071412,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,serotonin receptor activity (GO:0099589),0.5355314178984546,1.5860106844109858,0.027600849256900213,0.18316055890071412,0.998,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.36067409262121364,-1.5851034636928902,0.0017730496453900709,0.22977430522747114,0.999,62/181,23.06%,TACC1;MEF2A;CREBBP;RB1;KLF4;MIER1;NRIP1;GSK3B;RXRA;PRRX1;NFATC1;LMO2;DTX3L;SP1;TACC2;HDAC1;HES1;PPARA;NFKBIA;MED1;SPEN;JUN;MDFIC;ANXA4;SMARCE1;LDB1;PPARD;RBBP8;TAL1;TP53;RNF25;SIN3A;RERE;ZFPM1;BCAS3;MTDH;HDAC4;ACTB;ACTN4;PIAS2;SMARCD3;ATF4;TCF3;TADA3;MIER2;MAD2L2;GTF2I;CTNNB1;ARNT;CDK5RAP3;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;CREB1;TAF4B;NFE2L2;RELA;MYOCD;TBX3
prerank,nuclear localization sequence binding (GO:0008139),-0.5625129035442809,-1.5831062430807836,0.023465703971119134,0.22691861844309505,0.999,7/18,17.86%,BRAP;KPNA4;NFKBIA;KPNA3;NUP153;KPNA1;NUP214
prerank,calcium channel activity (GO:0005262),0.393762467378583,1.5779038327271235,0.0044444444444444444,0.18922672035096583,0.998,24/84,11.72%,SLC24A4;SLC24A2;OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;PKD1L2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;RYR2;TMCO1;CACNG3;CACNB4;CACNA1E;TRPM1;PKD1L1;CACNG2;CACNG4;TMC2
prerank,small GTPase binding (GO:0031267),-0.3662413995876639,-1.5767404265096943,0.0,0.23224649731842184,0.999,48/170,15.56%,UNC13B;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;PAK2;LRRK2;EXOC4;RANBP2;AFDN;STRN3;HPS4;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;ANKFY1;GOLGA4;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,insulin-like growth factor I binding (GO:0031994),-0.6068229133271338,-1.5697227329728185,0.03165735567970205,0.2401111030271114,1.0,5/13,4.35%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4
prerank,calcium ion binding (GO:0005509),0.32819300347064545,1.568463293608891,0.0,0.19662728918262118,0.998,69/323,12.82%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;MMP12;RYR3;SLC25A13;SPOCK1;DNER;ASTN2;SYT12;SYT11;TKT;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;CALM2;CDH12;GSN;PADI1;RYR2;RPH3A;CDH7;GJB2;ENPP3;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;SRI;HRC;RASGRP1;MYL2;CASQ1
prerank,sialyltransferase activity (GO:0008373),-0.5515472885333031,-1.5646227438138849,0.014925373134328358,0.2432533560459391,1.0,7/20,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;ST8SIA4;ST6GAL1;ST6GALNAC3;ST3GAL2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6413607251189394,1.5643202297674612,0.03909465020576132,0.19656292161719463,0.998,4/10,7.56%,B3GALT1;B3GALT4;B3GALT5;B4GALT7
prerank,phosphatidic acid binding (GO:0070300),-0.5489313269123671,-1.5602139749177257,0.02952029520295203,0.24545110906397494,1.0,4/19,3.26%,PITPNC1;RAPGEF2;PLTP;MARK1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5203141191695388,-1.5526264564455718,0.021621621621621623,0.25434030831486454,1.0,4/24,4.31%,DAB2IP;CERT1;PLA2G4A;GOLPH3L
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.38414955009971563,-1.5478469387589746,0.0035714285714285713,0.25815217956180103,1.0,25/100,15.42%,HIP1;CYTH3;DAB2IP;PARD3;MYO10;CERT1;FERMT2;IQGAP1;SH3PXD2B;PLA2G4A;ARAP3;GOLPH3L;ZFYVE26;TECPR1;AKT1;WIPI1;SNX12;ARAP1;FCHSD2;ANKFY1;PLEKHA4;SNX24;ZFYVE1;HIP1R;GAB2
prerank,lipid phosphatase activity (GO:0042577),0.5832579855705892,1.5468473886890481,0.05,0.2141874724872713,0.999,5/14,8.91%,PLPPR4;PLPPR1;PLPP2;SGPP1;PLPPR5
prerank,phosphatidylinositol binding (GO:0035091),-0.38876299498694655,-1.5464616120890682,0.003552397868561279,0.2543163065709566,1.0,25/91,15.96%,PARD3B;PITPNC1;HIP1;ESYT2;PARD3;ITPR1;FCHO2;MCF2L;WDFY1;ITPR2;SNX9;SCARB1;PICALM;WDFY3;SNX12;BCAS3;PLEKHF2;ANKFY1;SNX24;ZFYVE1;EXOC8;HIP1R;MITD1;SNX8;TNFAIP8L3
prerank,phosphatidate phosphatase activity (GO:0008195),0.6001919848782784,1.544447317107108,0.04157043879907621,0.21241327837152787,0.999,6/13,8.91%,LPIN1;PLPPR4;PLPPR1;PLPP2;PLPP4;PLPPR5
prerank,diacylglycerol kinase activity (GO:0004143),0.6075535355135131,1.541247793907088,0.0668103448275862,0.21136854385737933,0.999,3/11,1.83%,DGKK;DGKI;DGKQ
prerank,histone demethylase activity (GO:0032452),-0.49125885747519255,-1.5390786492228834,0.03189493433395872,0.2641348322058628,1.0,10/27,16.87%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;JMJD6;KDM5B
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6320182826007503,-1.5380033011275611,0.021660649819494584,0.26036374131158035,1.0,5/11,13.40%,UBR5;UBE2K;RBX1;UBE4B;UBE4A
prerank,glycine binding (GO:0016594),0.6192733140546505,1.5379973904824416,0.0449438202247191,0.21054092022761178,0.999,4/11,5.34%,GLRA3;GRIN2B;GLRA1;GNMT
prerank,GTPase regulator activity (GO:0030695),-0.34152055976181084,-1.5336744794744452,0.001692047377326565,0.26396631680795823,1.0,74/212,22.62%,PREX2;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;BCR;RGS3;ASAP1;RALGAPA1;RAB3GAP1;RGS5;SH3BP4;STARD8;IQGAP1;RALBP1;ARHGAP10;LRRK2;ARAP3;RANBP2;TBC1D1;RGS12;CHN1;TBC1D2B;SLIT2;PLCB1;TBC1D8B;JUN;WASL;USP6NL;SIPA1L3;TBC1D30;BNIP2;TBC1D14;MTSS2;ARHGAP17;STARD13;PDE6D;TBC1D22B;RASA4;RAB3GAP2;ARAP1;ARHGAP1;TBC1D22A;ARFGEF1;GDI1;RASA1;RIN2;ARHGAP28;RTKN;WNT11;LARS1;SEC23B;TBC1D20;SMAP2;ARHGAP22;ABR;PREX1;ALS2;ARHGAP29;ARHGAP35;TBC1D8;TBC1D17;ARHGAP26;TBC1D25;ARHGAP42;NF1;ASAP3;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARHGAP11A
prerank,AMP binding (GO:0016208),0.6009084388325971,1.5315712689476482,0.04434589800443459,0.21453327333375063,0.999,2/11,2.28%,MPPED2;ACSS2
prerank,5'-nucleotidase activity (GO:0008253),-0.59933831246912,-1.5298890667403915,0.03398926654740608,0.265093866784924,1.0,7/13,26.79%,NT5C2;NT5E;NT5C1A;NT5C3B;ACP3;NT5DC1;NT5C
prerank,anion channel activity (GO:0005253),0.41292240706197125,1.525573976214299,0.018823529411764704,0.2180645858622811,0.999,13/61,10.55%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;LRRC8E;ANO4;GABRA3;GABRA1;VDAC2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.3042251638190267,-1.5253099872655327,0.0,0.2681032511537022,1.0,195/831,18.47%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ETV6;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;RB1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;CUX1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;ZBTB46;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;BBX;STAT6;NFYC;E2F4;GTF2IRD1;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;TWIST2;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;ACTN4;PROX2;ZBTB6;KLF9;CREBRF;CIC;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;TRPS1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;ZBTB8A;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;RPS3;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF;EPAS1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5686617572686397,1.5166802071382581,0.04,0.22725755688532348,1.0,6/15,7.93%,HS6ST3;HS3ST6;HS3ST5;NDST4;HS6ST2;HS3ST2
prerank,insulin-like growth factor binding (GO:0005520),-0.5579382469243986,-1.5129507215330065,0.03985507246376811,0.2882958599405037,1.0,6/15,9.44%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4;IGF2R
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5347530091904065,-1.5071550860126222,0.03874538745387454,0.2946714243891961,1.0,6/18,14.44%,XIAP;TNFAIP8;BIRC3;GAS6;RPS6KA1;RPS6KA3
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3195641930833788,-1.5060790972620173,0.0,0.29082841717737273,1.0,96/335,17.01%,GRK5;PRKCH;SNRK;MAP3K20;ACVRL1;BCR;DYRK1A;CSNK1A1;NEK7;DAPK1;FAM20A;PRKCE;BMPR2;TLK2;GSK3B;CDK13;ATM;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;PRKD3;NEK6;MTOR;PRKD2;CAMK2G;CDK12;EGFR;TLK1;CSNK1G3;TGFBR2;STK3;STK24;MAST4;MAST2;STK35;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;PRKD1;AKT3;RAF1;GSK3A;ACVR2A;ALPK1;LATS2;MYLK;AKT1;SIK3;TAOK3;PRKAA1;WNK4;GAK;STK10;ILK;STK32C;IKBKE;BRAF;STK38;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;ULK2;MAP3K8;CDK6;MKNK2;MAPK8;PKN2;TRIO;RPS6KA3;MAP4K4;MARK2;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;MARK3;RPS6KC1;HIPK1;IRAK2;CDC42BPB
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5199784249612472,1.501530968001499,0.0539906103286385,0.24558225979252138,1.0,3/18,7.18%,AKR1C1;HSD17B7;HSD17B14
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4528502449238811,-1.5008077989048136,0.025380710659898477,0.2962184550783686,1.0,15/35,24.56%,FOXP1;NR3C1;HDAC1;TP53;KLF10;TAF1B;TAF1C;AGO2;H3-3A;DR1;RUVBL2;UBTF;RELA;SNAPC3;SMARCB1
prerank,tau protein binding (GO:0048156),-0.4391457876225836,-1.493569017106438,0.025547445255474453,0.3065142907451926,1.0,18/40,19.24%,DYRK1A;GSK3B;MARK1;SMAD2;ROCK1;GSK3A;PICALM;PRKAA1;DCTN1;ACTB;MARK2;ROCK2;LGMN;PPP2CB;FYN;MARK3;HDAC6;PPP2CA
prerank,protein kinase C activity (GO:0004697),-0.5668447308370778,-1.4927513435538313,0.06112054329371817,0.30239111385434086,1.0,5/14,8.54%,PRKCH;PRKCE;PRKD3;PRKCD;PRKD1
prerank,death receptor binding (GO:0005123),-0.555025756841508,-1.4905004630248022,0.046125461254612546,0.30214761583892175,1.0,6/15,23.22%,DAB2IP;EDA;NGF;FEM1B;CASP8AP2;RIPK1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.303828001504039,-1.489382029332518,0.0,0.2991514879948755,1.0,177/597,25.03%,FOXP1;KLF12;LEF1;PBX1;SMARCA2;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;BNC2;NFAT5;ELF1;KLF4;ETS1;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;SOX13;NFIX;SOX17;PSPC1;SP1;VSX1;ELK3;CTCF;NFKB1;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;NFYC;E2F4;GABPB2;CREB3L2;MAX;MEF2C;JUN;TBX2;SUV39H1;MCM9;BACH2;YAP1;PPARD;IRF1;GLI3;SMAD4;ZIC5;HSF5;SP3;TAL1;MCM4;GLIS2;ELF2;TP53;KLF10;HMBOX1;PER3;ETS2;NFIC;ORC5;PRRX2;GMEB1;SOX7;CHD3;FOXJ3;HDAC4;SFPQ;GABPB1;ASH2L;TFCP2L1;ZIC3;ATF4;MZF1;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;BCOR;ZNF32;NR2C1;PRDM9;SMAD6;ETV1;FOXO4;ZFP1;TAF7;HIC1;ORC2;KDM5B;SIX4;RARA;HOXA2;ARID5B;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;CARM1;ELK4;HOXB9;ZIC1;ZBTB12;HLF;ORC4;RNF10;GATA2;SOX4;TCF4;TCF7L2;NONO;TBL1X;PPARG;PRDM1;BCL6;RARB;BRCA1;FOXL2;GLIS1;HSF4;CREB1;ELF4;NFE2L2;GABPA;RELA;KCNH2;YY1;MCM3;TBX3;ATF6;MSX1;RXRG;RBBP5;CEBPA;BEND3;KLF16;ATF5;E2F7;GMEB2;E2F3;TAF9;ZNF276;HMGB1;EGR3;DHX9;IRF7
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5025545833032927,1.4882182492030507,0.03991130820399113,0.2621550663472407,1.0,3/21,6.92%,GRM5;GRIA1;GRM1
prerank,DNA-binding transcription factor binding (GO:0140297),-0.337818690491103,-1.4875616596757457,0.005244755244755245,0.2974206581677583,1.0,66/189,24.95%,MEF2A;CREBBP;RB1;KLF4;MIER1;TCF12;PRDM5;GSK3B;PRRX1;NFATC1;PRDM16;LMO2;SIK1;NEK6;SP1;HDAC1;HES1;PPARA;ZBTB7A;SPEN;MEF2C;JUN;SMAD2;YAP1;YWHAZ;LDB1;PPARD;RBBP8;TAL1;TP53;ZMYND8;SIN3A;RERE;ZFPM1;MTDH;HDAC4;KAT5;PIAS2;ATF4;HCFC1;TCF3;MIER2;FOXO4;MAD2L2;SKI;GTF2I;CTNNB1;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;HDAC7;CREB1;PTMA;NFE2L2;GABPA;RELA;MYOCD;TBX3;CRTC1;TAF9;TLE6;HMGB1;DHX9
prerank,neuropeptide binding (GO:0042923),0.5131619829085939,1.4839563670899845,0.053452115812917596,0.2624779385185572,1.0,5/18,16.85%,OPRM1;GPR37;SORL1;NMUR2;GPR149
prerank,5'-3' exonuclease activity (GO:0008409),-0.5756226982566972,-1.4822267946427174,0.06641366223908918,0.30291829501517475,1.0,10/14,36.58%,XRN1;MRE11;XRN2;EXOG;DCLRE1B;DCLRE1A;DXO;EXO1;FAN1;DCP2
prerank,potassium ion antiporter activity (GO:0022821),0.5458995704413235,1.4821568691097464,0.0598669623059867,0.25972132823444777,1.0,4/15,5.25%,SLC24A4;SLC24A2;SLC9A7;SLC9A9
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4939333409326884,-1.4740647712359025,0.048214285714285716,0.31553327775431594,1.0,7/23,9.00%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2
prerank,acetyltransferase activity (GO:0016407),-0.46544964518837917,-1.4640950866421238,0.045454545454545456,0.33285564063268325,1.0,9/31,11.31%,CREBBP;KAT6B;KAT2B;KAT6A;NAA16;NAA80;SMARCE1;NAA15;GNPNAT1
prerank,kinase binding (GO:0019900),-0.3046979259045221,-1.463298509951338,0.0,0.32860792233535124,1.0,139/434,24.36%,UTRN;DAB2IP;TTC28;GHR;SLC12A7;SP100;ACVRL1;RB1;FERMT2;PPP2R5A;CAV1;RAC1;ESR1;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;RND3;CRK;PAK2;WWC2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;LRBA;PTPRJ;EGFR;SLC12A2;TFRC;CDKN1B;NISCH;TAX1BP1;MSN;HNRNPA0;RICTOR;AP2A2;DLG1;FOXO3;FAS;CCND3;CEP250;PTK2;IRGM;PRKCD;PTPRK;CNTLN;ZBTB4;SMAD1;ACTA2;MAML1;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;CSPG4;CTBP2;BCAR1;ADAM10;MYOM1;TP53;FLNA;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;RHOA;IRAK1;ACTB;CEACAM1;DUSP3;MTCP1;CHP1;GYS1;RHOC;RHOG;ATF4;PARN;PIK3IP1;GRB2;KIF11;SKI;CTNNB1;TNS2;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;RAD23A;TRPV4;CEP152;IKBKB;NOD2;CCND1;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;SIKE1;PDGFRB;HDAC7;MAP2K3;TOM1L2;CDC25A;IFNAR2;RPS7;GADD45A;RELA;PTN;PARP16;PIP5K1A;BECN1;CASP1;TPCN2;CEBPA;FZD5;TRIM68;TRIB3;ATF5;CCNK
prerank,neurexin family protein binding (GO:0042043),0.6140381877356507,1.462347453054835,0.05592841163310962,0.2868611670020121,1.0,6/10,19.35%,NLGN1;SYTL2;CPE;NLGN2;SYTL1;NLGN3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.521131956455862,1.4617295727447188,0.07658643326039387,0.2769601500109548,1.0,5/17,5.49%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,ephrin receptor activity (GO:0005003),0.521131956455862,1.4617295727447188,0.07658643326039387,0.2769601500109548,1.0,5/17,5.49%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5696907762466168,1.459084022076769,0.1,0.2761443076493758,1.0,3/11,8.86%,SLC22A4;SLC22A1;SLC25A45
prerank,peptide hormone receptor binding (GO:0051428),0.5778754712926069,1.4584186336861802,0.06772009029345373,0.27215324172064614,1.0,2/11,10.26%,PSMC5;CCK
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.47112638818575936,-1.4523368839079716,0.05263157894736842,0.3486804314084175,1.0,7/26,10.66%,ABCG2;SLC6A6;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLC16A6
prerank,protein kinase binding (GO:0019901),-0.30116296263400316,-1.452003312070701,0.0,0.34355756720302777,1.0,150/479,22.67%,UTRN;GRK5;DAB2IP;GHR;SLC12A7;ITGB1;ACVRL1;FERMT2;CAV1;RAC1;ESR1;CAVIN2;BMPR2;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;RND3;CRK;PAK2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;PRKD2;LRBA;PTPRJ;ACE;SLC12A2;TFRC;CDKN1B;NISCH;MSN;ADAM9;PDLIM5;HNRNPA0;RICTOR;AP2A2;IRS1;DLG1;ABL1;FOXO3;PPEF2;PARD6G;CCND3;CEP250;GCH1;PTK2;KCNQ1;IRGM;PRKCD;PTPRK;CNTLN;EZR;MAPKAPK2;CDH5;TJP2;ZBTB4;SMAD1;ACTA2;ADCY4;MAML1;EPHA4;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;GSK3A;CSPG4;CTBP2;BCAR1;ADAM10;TP53;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;STK38;RHOA;IRAK1;ACTB;CEACAM1;PRKCSH;DUSP3;MTCP1;NEDD9;GYS1;RHOC;CSK;RHOG;ATF4;PARN;GRB2;TCF3;KIF11;TPR;MAD2L2;SKI;NOX4;RARA;HINT1;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;TRPV4;CEP152;IKBKB;NOD2;PPM1D;DUSP16;CCND1;DUSP22;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;ROR2;SIKE1;PDGFRB;HDAC7;SPAG9;MAP2K3;TOM1L2;CDC25A;MAPK7;IFNAR2;RPS7;HSP90AA1;RELA;PTN
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.47547234941839506,1.449464671511604,0.07488986784140969,0.2817426400195744,1.0,7/24,10.34%,AK9;ITPKA;AK7;AK5;AK3;NME2;IP6K2
prerank,vitamin D receptor binding (GO:0042809),-0.561149883545044,-1.4486263309059633,0.06822262118491922,0.34590430675269535,1.0,6/14,16.25%,RXRA;MED1;TAF11;MED13;MED17;TAF7
prerank,transaminase activity (GO:0008483),0.5666405452115673,1.4473772098142912,0.08295964125560538,0.27978679124841815,1.0,2/11,3.11%,GOT1L1;OAT
prerank,histone deacetylase binding (GO:0042826),-0.3668234802113274,-1.446343709230355,0.023809523809523808,0.3456701767723262,1.0,32/88,23.08%,LEF1;MEF2A;MIER1;KAT2B;YWHAE;SP1;NIPBL;HDAC1;HES1;MEF2C;GLI3;TAL1;TP53;HDAC4;SFPQ;MAPK8;PKN2;PHF6;BCOR;MIER2;HIC1;HDAC6;TFAP4;HDAC10;HEY2;MIER3;CCND1;PRDM1;NACC1;HSP90AA1;RELA;SUDS3
prerank,transcription cis-regulatory region binding (GO:0000976),-0.30603728733574237,-1.4444345015054505,0.001658374792703151,0.34468949429385104,1.0,124/406,24.69%,FOXP1;LEF1;PBX1;RREB1;SMARCA2;FLI1;ETV6;ZBTB20;MEF2A;RB1;BNC2;KLF4;ETS1;CUX1;FOXN3;TCF12;PRDM5;IRF2;RXRA;PRDM16;FOSL2;TEAD1;NR3C1;SOX13;TIPARP;PLAGL1;SOX17;PSPC1;ZBTB46;SP1;VSX1;ELK3;CTCF;HDAC1;NFKB1;LHX6;SIX1;FOXO3;BBX;STAT6;NFYC;GABPB2;CREB3L2;MAX;MEF2C;JUN;ZBTB4;SMAD2;ZFP90;SUV39H1;DACH1;YAP1;PRDM2;IRF1;GLI3;ZNF25;SMAD4;SP3;TAL1;GLIS2;TP53;KLF10;PER3;SOX7;CHD3;TWIST2;XRN2;FOXF2;HDAC4;SFPQ;GABPB1;ACTN4;CREBRF;ASH2L;CIC;ATF4;MZF1;AGO2;GRHL1;HIF3A;TCF3;FOXC1;BCOR;PRDM9;SMAD6;DR1;TAF7;TRPS1;RARA;ARID5B;ZBTB14;ZBTB8A;TFAP4;ARNT;CARM1;RPS3;EPAS1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;PBX2;NFE2L2;GABPA;RELA;KCNH2;YY1;SNAPC3;ATF6;MSX1;RFXANK;RBBP5;CEBPA;ATF5;ZFP3;E2F7;E2F3;TAF9;TFDP1;HMGB1;RBAK
prerank,transcription coregulator binding (GO:0001221),-0.4064048422592063,-1.4413277182222994,0.03544776119402985,0.34674181055297754,1.0,14/50,10.52%,ZBTB16;ESR1;LMO2;THRB;NEK6;VGLL4;CTCF;ZBTB7A;SUZ12;PPARD;SMAD4;CTBP2;EHMT1;PER3
prerank,voltage-gated ion channel activity (GO:0005244),0.5317063419148019,1.4345708340058454,0.07643312101910828,0.2961199642603858,1.0,4/14,10.55%,KCND2;HCN1;CACNA1E;VDAC2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5543006961404565,-1.4294876975469346,0.07334525939177101,0.36798778644130575,1.0,8/13,25.35%,PIP4K2A;PIP4K2B;PIP5K1B;PIK3C2A;PIK3CD;PIK3CB;PIP5K1A;PIK3CA
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4424103323032157,-1.4266490654671378,0.040421792618629174,0.36910738474922605,1.0,13/34,16.06%,SETD2;KMT2E;KMT5B;NSD3;SUV39H1;SETD3;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;ANTKMT
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.38223745860679054,-1.4235783147087213,0.03264604810996564,0.3711132095543909,1.0,20/71,12.96%,PTPRG;PTPRB;PTPRM;PTPN14;PTP4A2;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PTPDC1;CDC14A;PTPRK;PALD1;MTMR6;PTPN3;DUSP23;DUSP3;PTPN13
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.4455363709408672,-1.42256687403263,0.06692160611854685,0.3682456676289137,1.0,8/30,14.44%,CAST;XIAP;TNFAIP8;BIRC3;GAS6;BIRC6;RPS6KA1;RPS6KA3
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3147262124413846,-1.408437892948581,0.005050505050505051,0.3982935006622281,1.0,86/228,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;UBE2K;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;UBR4;UBE4A;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5137700965502724,1.4082394179697617,0.07882882882882883,0.33796154670972545,1.0,4/16,8.27%,SLC22A4;SLC22A1;SLC7A8;SLC29A4
prerank,death receptor activity (GO:0005035),-0.5796279816651616,-1.40304031490656,0.09929078014184398,0.4064444978606516,1.0,5/11,20.19%,TNFRSF1B;FAS;TNFRSF19;TNFRSF1A;TNFRSF25
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.550219582730153,-1.3950638746191797,0.09345794392523364,0.4211158258152136,1.0,7/12,31.75%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.43164598892260264,-1.3938948492373686,0.0718132854578097,0.41835132632331906,1.0,16/34,27.04%,PAN3;ERI3;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT2;EXOSC7;TOE1;CNOT8;CNOT1
prerank,protein phosphatase binding (GO:0019903),-0.34393476217070085,-1.3930172774812493,0.020942408376963352,0.41490582171578305,1.0,28/117,12.97%,DAB2IP;FOXO1;MFHAS1;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;AKAP11;CDKN1B;PPP1R3B;PXN;STRN3;PIK3R1;SHOC2;PHACTR4;PTK2;KCNQ1;STAT6;CDH5;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3;CTTNBP2NL
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.40429927001271254,-1.3890509121058459,0.058419243986254296,0.4198566360398564,1.0,16/42,16.18%,CRK;SHE;LDLRAP1;YWHAE;YES1;PIK3R1;IRS1;ABL1;NEDD4;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,sodium channel regulator activity (GO:0017080),0.4140081086738271,1.3880273097817104,0.05869074492099323,0.37285970943424135,1.0,12/37,17.91%,FGF14;FGF12;SCN1B;ATP2B4;PKP2;GPD1L;GPLD1;SGK1;FXYD4;SCN2B;SGK3;SGK2
prerank,phospholipase C activity (GO:0004629),-0.45894632368079724,-1.3873152476886035,0.07312614259597806,0.4186317851805333,1.0,8/25,13.14%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2;PDIA3
prerank,transcription coactivator binding (GO:0001223),-0.4775120415617179,-1.386195583723034,0.08719851576994433,0.41629948960115676,1.0,5/20,9.29%,ESR1;THRB;VGLL4;PPARD;SMAD4
prerank,methyl-CpG binding (GO:0008327),0.45405574459930675,1.385009029039929,0.08974358974358974,0.3723565962876828,1.0,11/22,24.37%,ZCWPW1;CXXC4;UHRF1;ZBTB21;PRMT5;TET1;CXXC5;CHTOP;ERH;WDR77;LHX4
prerank,histone methyltransferase activity (GO:0042054),-0.4361171776476998,-1.3845948149195553,0.06747404844290658,0.41510947512277907,1.0,14/32,18.02%,SETD2;KMT2E;KMT5B;NSD3;SUZ12;SUV39H1;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C;CARM1
prerank,estrogen receptor binding (GO:0030331),-0.4265062080601333,-1.3828471394427362,0.0692167577413479,0.414407634617014,1.0,12/32,19.09%,LEF1;TACC1;NSD1;ESR1;NRIP1;MED1;WIPI1;RERG;DCAF13;CTNNB1;WBP2;NCOA6
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.37138810519737164,-1.3803763751749378,0.05730129390018484,0.41524478495405975,1.0,14/60,9.44%,FLT1;TEK;IGF1R;NRP2;TIE1;ROR1;INSR;CRIM1;KDR;MERTK;EGFR;EPHA4;FLT4;IGF2R
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.5856830708838152,-1.3801947265459742,0.0989010989010989,0.41063273080589,1.0,3/10,10.04%,NAA16;NAA80;NAA15
prerank,phosphatase activity (GO:0016791),0.3497231627887366,1.3798629315432576,0.04176334106728538,0.37676736381670906,1.0,20/73,15.83%,ATP1A2;BPNT2;LPIN1;PLPPR4;PPP5C;PLPPR1;PLPP2;DUSP4;SBF1;PLPP4;PLPPR5;HDHD2;OCRL;APTX;DUSP8;NUDT16;DUSP15;PSPH;PTPRO;FRA10AC1
prerank,histone acetyltransferase activity (GO:0004402),-0.43544628805578506,-1.3766424442739011,0.07330827067669173,0.414424053893181,1.0,9/30,15.40%,CREBBP;KAT6B;KAT2B;KAT6A;BAZ1A;SRCAP;KAT5;MCM3AP;TADA3
prerank,sequence-specific DNA binding (GO:0043565),-0.2797072386794811,-1.3764515132892745,0.003105590062111801,0.4099462331928637,1.0,125/590,18.47%,FOXP1;KLF12;LEF1;PBX1;FOXP2;FLI1;MBNL2;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;CBFB;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;STN1;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;KDM2A;ZBTB37;SOX13;NFIX;SP1;ZNF148;VSX1;ELK3;CTCF;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;UPF2;JUN;ZBTB4;TBX2;BACH2;PRDM2;PPARD;GLI3;SMAD4;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;PRRX2;GMEB1;SOX7;FOXF2;FOXJ3;SNAPC1;HDAC4;SIRT3;CTC1;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;ZNF32;NR2C1;PRDM9;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;ELK4;HOXB9;ZIC1;ZBTB12;HLF;EPAS1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5458506474608538,-1.3761586630727158,0.10288808664259928,0.40584916147475913,1.0,7/13,27.34%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.5178323602081516,-1.3732553839272117,0.1049618320610687,0.40823420583466413,1.0,7/15,16.18%,ATM;PI4KB;PIK3C2A;PIK3CD;PIK3CB;PI4K2B;PIK3R3
prerank,G protein-coupled receptor activity (GO:0004930),0.2960352251342766,1.3723864023774506,0.002531645569620253,0.38567001084850117,1.0,38/239,12.02%,GRM5;ADGRB3;HCRTR1;PROKR1;OPRM1;ADGRL3;GRM8;NPFFR2;GPR101;ADGRG4;GABBR2;CNR1;GPR135;MTNR1B;GPR37;ELOVL4;MTNR1A;GPR22;GRM1;NPY;KISS1R;TRHR;ADRA2C;C3AR1;GIPR;ADRB3;ADRA2A;GPR83;GPR65;TSHR;LGR5;VIPR2;ADRA1D;ADRA1A;NMUR2;GPR45;CELSR2;GABBR1
prerank,actin monomer binding (GO:0003785),-0.4652722317985428,-1.3703355339695553,0.08797127468581688,0.41020677206053685,1.0,5/22,5.93%,LIMA1;NOS3;PRKCE;TMSB4X;ABL1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.36845928552784285,-1.365568578022998,0.05947955390334572,0.4178057340805339,1.0,14/60,9.17%,FLT1;TEK;IGF1R;ACVRL1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;TGFBR2;EPHA4;FLT4;ACVR2A
prerank,syntaxin-1 binding (GO:0017075),0.45875830773802606,1.3630941364010019,0.10416666666666667,0.3997013932699474,1.0,7/22,7.80%,SYT1;SNAP25;SNPH;SYNPR;PRRT2;SYP;STXBP2
prerank,growth factor activity (GO:0008083),0.346830722583173,1.3627523395651817,0.044444444444444446,0.39407385873683665,1.0,13/74,13.39%,NRG3;NRG1;OSGIN1;CLEC11A;FGF6;GRN;FGF5;VEGFA;PDGFA;IL12A;THPO;BDNF;FGF20
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5267100322052891,-1.3621529153136225,0.0924956369982548,0.4211822825918521,1.0,6/14,19.46%,USP9X;MINDY1;USP13;USP15;ATXN3;USP7
prerank,filamin binding (GO:0031005),-0.5466101065197277,-1.3582285572831978,0.11610486891385768,0.4255548491463374,1.0,8/11,36.40%,NEBL;CEACAM1;SYNPO2;CRMP1;RFLNB;RFLNA;DPYSL4;FBLIM1
prerank,nuclear receptor binding (GO:0016922),-0.3318563729721535,-1.3578743926269716,0.028985507246376812,0.4214722002799373,1.0,29/111,17.12%,FOXP1;LEF1;TACC1;NSD1;ESR1;ASXL1;NRIP1;RXRA;TACC2;ZBTB7A;MED1;PRPF6;SMARCE1;TRIP12;TAF11;MED13;WIPI1;KDM3A;JMJD1C;BCAS3;MED17;ACTN4;HMGN3;SMARCD3;TADA3;RERG;TAF7;DCAF13;CTNNB1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5516693692062125,1.3559341079570164,0.1261061946902655,0.4019614188628273,1.0,2/10,1.82%,DPP10;DPP6
prerank,bHLH transcription factor binding (GO:0043425),-0.47818407011244723,-1.3559051722846858,0.10611510791366907,0.42173287881203736,1.0,4/19,4.96%,CREBBP;TCF12;LMO2;SP1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.45118080581572184,-1.35552849907401,0.08286252354048965,0.4180784982981423,1.0,10/25,22.11%,HIP1;ARAP3;AKT1;FCHSD2;PLEKHA4;ZFYVE1;HIP1R;GAB2;PHLDA3;KIF16B
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3020174514468629,-1.352928057824223,0.011884550084889643,0.4197142041611513,1.0,86/232,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;NSMCE2;PIAS2;UBR4;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;PIAS4;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.4322166936581703,-1.3511227742843355,0.11229946524064172,0.42005525696356716,1.0,21/29,40.43%,NFATC1;PTPRJ;ACE;ABL1;GCH1;MAPKAPK2;TPR;CDK5RAP3;PPM1D;DUSP16;MAPK7;TNIP1;DUSP1;MAPK14;DUSP6;DIRAS1;ATF7;DUSP5;MAPKAPK5;DUSP2;SIRT1
prerank,transforming growth factor beta binding (GO:0050431),-0.4594219250024162,-1.349062582439727,0.10112359550561797,0.4207007770121683,1.0,5/23,5.09%,ENG;ACVRL1;THBS1;TGFBR3;TGFBR2
prerank,histone acetyltransferase binding (GO:0035035),-0.4558148983409663,-1.348297284339584,0.10211946050096339,0.4182831057109993,1.0,10/21,23.92%,MEF2A;ZBTB7A;GLI3;TP53;BCAS3;TAF7;EPAS1;CITED2;KANSL1L;TRIM68
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5375383456047143,-1.346710213982907,0.12570356472795496,0.41762226329227425,1.0,6/12,16.18%,ATM;PIK3C2A;PIK3CD;PIK3R6;PIK3CB;PIK3R3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.44008222077199355,1.3441322985332222,0.09339407744874716,0.42105901841588683,1.0,7/23,10.02%,PDE4B;PDE3B;PDE1B;PDE10A;CNP;PDE1A;PDE11A
prerank,DNA binding (GO:0003677),-0.2705033175899531,-1.3411274972417502,0.0015748031496062992,0.42659757745862237,1.0,204/694,25.19%,MECOM;KLF12;LEF1;PBX1;FOXP2;SMARCA2;FLI1;ZBTB16;NFIB;ZNF423;ERG;FOXO1;MEF2A;CREBBP;CBFB;ETS1;CUX1;HIVEP2;PDS5B;PRDM5;KLF2;CHD2;IRF2;RXRA;STN1;APP;RBMS1;PRDM16;TEAD1;TBX1;THRB;DDX3X;SOX13;KAT6A;PLAGL1;PARP4;EGFR;SP1;DMC1;ZNF148;CRLF3;CTCF;TOP3A;ZMYM6;HES1;PPARA;MEOX2;RARG;SIX1;RBM5;RYBP;ABL1;ZBTB7A;SAMHD1;FOXO3;ZIC4;XRCC4;NFYC;E2F4;XRN1;MAX;JUN;ZBTB4;SMAD2;MRE11;TSHZ2;TBX2;POLR2G;NABP1;MCM9;PRDM2;PPARD;IRF1;SMAD4;ERCC2;RBBP8;SPTY2D1;CLSPN;MCM4;TP53;BCLAF3;WDR76;HMBOX1;ETS2;RTF2;DDX60;ENDOV;CHD3;YAF2;FOXF2;FOXJ3;RAD18;SNAPC1;RTF1;HDAC4;SFPQ;ZNF638;OGG1;ZMYM4;LRRFIP1;RPA3;DNA2;JRKL;ZBTB6;RPA1;SIRT3;CTC1;PNKP;XPC;MECP2;ZIC3;ATF4;NHEJ1;ARID3B;GRHL1;ERCC3;HNRNPA1;TCF3;TCF7L1;POLR3F;FOXC1;CGAS;NR2C1;PRDM9;TRIM16;PALB2;FOXO4;HIC1;DNMT1;KDM5B;RPS27;ARID5B;ZBTB14;TFAP4;FANCG;ARNT;PATZ1;FUBP1;CEBPG;ZMYND11;HEY2;TSHZ1;WRN;RPS3;RAD23A;ELK4;SDE2;HLF;EPAS1;RPA2;ZDHHC1;RNF4;SMARCAD1;PRKDC;TCF4;TCF7L2;TIMELESS;PPARG;BCL6;RARB;HUWE1;LIG4;BRCA1;RAD51AP2;NR2F2;TRIM28;FOXL2;DCLRE1B;TERT;BLM;RBM6;TSHZ3;TAF4B;NFE2L2;RELA;RPS15;YY1;MBD6;MCM3;TOP1;NTHL1;SNAPC3;TBX3;ATF6;RFC1;PCBP1;GTF3C4;CEBPA;MSH3;THRAP3;ATF5;MAU2;ARID3A;E2F3;TAF9;SMARCB1;HMGB1;KHDRBS1;DHX9;INO80;IRF7;DCLRE1A;HIC2;FOXF1
prerank,BMP receptor binding (GO:0070700),-0.5458677903875817,-1.3378102599288217,0.11711711711711711,0.42996426872138843,1.0,7/12,27.34%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,double-stranded DNA binding (GO:0003690),-0.27490008421477846,-1.3372708364505097,0.0016155088852988692,0.4267173013761277,1.0,113/531,18.46%,FOXP1;KLF12;LEF1;PBX1;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;KLF2;IRF2;RXRA;KLF3;RBMS1;NFATC1;TBX15;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;NFIX;EGFR;SP1;DMC1;VSX1;ELK3;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;JUN;SMAD2;MRE11;TBX2;BACH2;PPARD;GLI3;RBBP8;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;DDX60;PRRX2;GMEB1;SOX7;FOXJ3;ZNF638;PNKP;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;POLR3F;MYBL2;CGAS;ZNF32;NR2C1;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;ZMYND11;HEY2;RPS3;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4265799869606237,-1.333479810636886,0.09906542056074766,0.43232863853050585,1.0,10/30,20.73%,SLC39A10;SLC40A1;SLC31A1;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC25A28;SLC39A6;SLC30A1
prerank,syntaxin binding (GO:0019905),0.3536221972835338,1.3314805496684892,0.057692307692307696,0.4420782301874827,1.0,11/61,7.80%,STXBP5L;SYT1;SYT5;SNAP25;SNPH;SYNPR;SYT12;CACNA1A;PRRT2;SYP;STXBP2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5483918600194431,1.3305756091839966,0.14408602150537633,0.4374894323926754,1.0,4/11,10.43%,FBXO11;PRMT9;PRMT6;PRMT5
prerank,store-operated calcium channel activity (GO:0015279),-0.5578102811444599,-1.3289536329703402,0.1384083044982699,0.4386147258138278,1.0,4/10,16.74%,STIM2;TRPC4;TRPC6;TRPC3
prerank,metalloexopeptidase activity (GO:0008235),0.3658693685847228,1.3278634090316634,0.08466819221967964,0.4368920562713757,1.0,14/51,14.22%,AGBL4;CPB2;TRHDE;MMP16;CPA2;CPE;METAP2;AGBL1;DPEP1;CPN1;AEBP1;NUDT16;CPA4;CPA3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.399391720407147,-1.3260998312211358,0.08426966292134831,0.4414678507293158,1.0,13/37,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,signal sequence binding (GO:0005048),-0.4036975324783433,-1.3260970081450927,0.0944741532976827,0.4372335111724429,1.0,19/35,32.00%,BRAP;KPNA4;AP2B1;NFKBIA;KPNA3;KDELR3;NUP153;CAT;BABAM2;KPNA1;NUP214;AP2M1;RANBP6;TOMM20;SEC61A1;TOMM70;KDELR1;TNPO2;CEMIP
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5127047423374069,-1.3256404718589818,0.13609467455621302,0.4341659193091447,1.0,5/14,18.95%,FHIT;NUDT13;ENPP4;NUDT6;NUDT12
prerank,Wnt-activated receptor activity (GO:0042813),-0.5021268679695676,-1.324368860536459,0.12363636363636364,0.4334837610967604,1.0,9/15,26.46%,ROR1;LRP5;FZD6;FZD4;FZD7;FZD5;FZD10;TSPAN12;FZD1
prerank,SH2 domain binding (GO:0042169),-0.4177839366352634,-1.3239532009489736,0.0974264705882353,0.4305802878456492,1.0,8/31,6.61%,AFAP1L2;RUFY1;CRK;SH3PXD2B;ARHGAP5;IRS1;ABL1;PTK2
prerank,RNA binding (GO:0003723),-0.2555930714858539,-1.3231093403125609,0.0,0.4283499228555459,1.0,460/1321,29.27%,SPTBN1;MBNL1;TNS1;CTNNA1;RBPMS;MBNL2;CAST;MAP3K20;MSI2;SRSF11;EIF3H;FNDC3B;ANKHD1;MYH9;FNDC3A;ZCCHC7;ANKRD17;YARS1;ZNFX1;TNRC6B;TUT7;HADHB;ERI3;RBFOX2;SUGP2;CHD2;TMSB4X;EIF4H;IFIH1;ZNF326;ANXA2;CDK13;TENT4B;PTPN1;TRIM25;RBMS1;TRIM56;RRBP1;PRPF3;NUP42;DEK;CNOT4;ZC3HAV1;ANXA11;RPS21;DAP3;EIF3E;METTL14;ARCN1;SYNE1;UTP11;DDX3X;DIAPH1;MAP4;RPL37;AHNAK;YWHAE;RAE1;FBRSL1;SARNP;RPL31;GIGYF2;PSPC1;TFRC;ZC3H4;SUCLG1;MSN;RTRAF;HNRNPA0;EIF3C;LARP1;THOC2;RPL9;PPIG;RBM5;RPS14;PRRC2B;WDR75;SAMHD1;NOVA2;HNRNPR;HOXB6;KHNYN;FARS2;SORBS2;RPF1;MACF1;UPF3B;FUS;NOL10;AATF;PRPF6;DDX10;SNTB2;RBM33;ACIN1;NUP98;SF3B6;EIF3B;SPEN;XRN1;ZCCHC9;RPSA;TCP1;RBMS2;SAMD4A;PUM1;EZR;JUN;TOP3B;MYO18A;RBM19;HNRNPM;ZC3H7B;FAM120C;S100A16;AGFG1;SECISBP2;ZGRF1;DDX50;POLR2G;PRKRIP1;HNRNPAB;NOP2;YWHAZ;EXOSC2;PHF5A;EXOSC1;ADK;CELF1;PTCD3;DDX39B;ZNF106;RPL3;SF3B1;MRPL32;GTF2E2;SRPRA;GPATCH8;RPL26;ESF1;NAA15;TASOR;DNTTIP2;FLNA;PUF60;PPP1R10;PRPF31;CPSF7;RPS11;SNIP1;NDUFV3;SRP9;HNRNPA3;SLC25A11;DICER1;FAM120A;HNRNPUL1;HELZ2;EXOSC3;TDRD3;SERBP1;EFTUD2;PRRC2C;DDX60;RBM39;PEBP1;DHX38;DBR1;EEF2;ENDOV;MAZ;MRPS23;OTUD4;HNRNPF;CHD3;XRN2;TUT4;SON;RPL13;MTCL1;ACTN1;ALDH18A1;MTDH;SPATS2L;RTF1;SFPQ;ZNF638;PA2G4;STRBP;LLPH;LRRFIP1;KCTD12;UTP3;ACTN4;TIAL1;DNA2;RPL38;CLK3;PDIA3;EIF5A;RRP1;RPL27;NIP7;RPS16;LARP4B;APOBEC1;XPOT;RPS4X;MECP2;PKN2;MRPL2;PARN;GSPT1;NUFIP2;AGO2;RPL10;MRPS24;RBM20;RPL7A;RPUSD4;RC3H1;FAM98A;GRB2;SF3A1;FAU;MARK2;HNRNPA1;LARP1B;CCDC9;N4BP1;PHF6;MRPS27;MRPL12;SYNCRIP;CCDC9B;ROCK2;ZC3H14;PABPC4L;HARS2;JMJD6;KMT2C;USP10;DARS2;TPR;RPL5;UBE2L3;PUS10;ALG13;CAVIN1;TEP1;SRSF12;LBR;PSTK;DCAF13;SRP14;UTP14A;MOV10;SRPK2;SUMO1;GCN1;RPS27;CCDC86;API5;ADARB1;RPL27A;TRMT9B;EDC3;FUBP1;PPHLN1;DIDO1;LSM10;RPL7L1;RPS3;ATP5F1C;RBM4B;DHX57;NCOA5;STAU1;TES;BUD13;HMGN2;RPL36A;COA6;RPL35A;TNRC6A;FIP1L1;DDX31;UTP4;PRKDC;SRRM1;FARSA;BOP1;MRPS14;TXN;NONO;DCP1A;CAPRIN1;RNPS1;CDK11B;RPL37A;SRSF3;NQO1;PSMD4;HUWE1;BRCA1;PTBP3;DUSP14;PES1;RTCB;MRPS21;TRIM28;STRAP;RRS1;DROSHA;BZW1;RBM3;SRSF10;TERT;RPL32;TRA2B;FASTKD5;NKAP;MEX3A;SLC3A2;PRPF38B;ARHGEF1;LSM3;RBM6;MEX3B;EBNA1BP2;CWC22;METTL16;UBTF;RPS7;MRPL54;HSP90AA1;TPD52L2;KTN1;RPS15;RBM25;YY1;TOP1;RPS8;ALKBH5;RPL28;RPL22;AKAP1;RPL13A;MRPL13;NPM3;MRPL9;RPL36;EIF3A;RPL30;ZCCHC24;RBM15;NOP16;PCBP1;RPS23;TRMT1;THRAP3;POLDIP3;SMG6;SF3B5;HSPA1B;NXF1;TAF15;HMGB1;NEMF;SRBD1;ELAC2;GLRX3;IMMT;NOA1;RPS17;EIF3I;PINX1;KHDRBS1;DHX9;MRPS28;MRPS35;NOL8;EXOSC7;UBAP2;WDR46;FXR1;NCBP3;RPS2;MRPL43;PRPF40B;RBM28;FAM32A;IGF2BP2;TOE1;PEF1;EIF2AK4;TUFM;ZFP36L1;ENDOU;RPP30;LRP1;RTCA;TRNT1;RBM47;RPL39;MRPL11;RPS26;NAF1;RPS15A;HNRNPL;HNRNPD;DXO;RAN;RBPMS2;MRPS31;NANOS1;BYSL;SELENOH;LARP6;RPL15;RPL34;CNOT1;EIF5B;EMG1;PABPC1;BAG4;NMD3;HNRNPU;SCAF11;SLTM;RPL22L1;SMG1;HDLBP;PCDH20;POP4;RDX;HTATSF1;LSM2;TDRD7;SCG3;OASL;BST2;DMGDH;NUFIP1;DHX40;UTP23;UBE2I;DDX28;KHDC4;NUDT7;UBA1;UTP20;MTIF2;RPUSD2;SPATS2;PPIE;RAD51AP1;ZFR;EIF4G3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4399953191433374,-1.3228809004278026,0.1265597147950089,0.4251142450330444,1.0,11/25,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;PARP16;PARP6;PARP9
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5395095441728671,1.3222419094857096,0.1506849315068493,0.4426129131001221,1.0,1/11,0.61%,HCN1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.48433072344794115,1.3222096154158085,0.13291139240506328,0.4304523479259395,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.48433072344794115,1.3222096154158085,0.13291139240506328,0.4304523479259395,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,calcium-activated potassium channel activity (GO:0015269),0.5345647610306494,1.321859670442612,0.14757709251101322,0.4253862438104879,1.0,3/11,11.47%,KCNMA1;KCNN2;KCNN3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5099994525550906,-1.3214516674639987,0.13644524236983843,0.42453918052180223,1.0,5/13,13.35%,GSK3B;KCNQ1;EZR;GSK3A;CSK
prerank,triglyceride lipase activity (GO:0004806),-0.4539295434096126,-1.3204457423519296,0.1320754716981132,0.42281866845850546,1.0,7/20,29.49%,LPL;LIPE;DAGLB;DDHD2;LCAT;PNPLA2;LIPH
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5436927913506855,-1.317701697440018,0.15285451197053407,0.42541712201032245,1.0,6/11,18.94%,STN1;RPA1;CTC1;HNRNPA1;TERF2;RPA2
prerank,metallopeptidase activity (GO:0008237),0.31477947707609827,1.3175498526428557,0.03879310344827586,0.4286854860295504,1.0,21/113,9.76%,ADAM12;OMA1;ADAM23;ADAM29;MMP12;MME;ADAM11;MMP16;MMP28;MMP24;MMP25;PAPPA2;ADAMTS15;METAP2;ADAMTSL4;ADAM2;DPEP1;MPND;PSMD14;ADAM19;ADAMTS16
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3608115043969186,-1.3158061113450472,0.0817391304347826,0.42602881211071864,1.0,15/60,11.07%,PPM1H;MTMR3;LRRK2;CAMK2G;PPEF2;LRRK1;PPM1L;CDC14A;ILKAP;MTMR6;PPM1F;CTDSPL2;PPP1R3C;PPM1B;UBLCP1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2815595293562209,-1.314718299047944,0.01340033500837521,0.4249561093520814,1.0,126/346,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRAF5;UBE2K;TRIM25;TRIM56;CNOT4;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;FBXL3;BIRC3;RNF213;RBX1;CBL;RNF43;LMO7;CUL3;NEDD4;LTN1;RNF40;RNF115;RNF144B;CUL2;BIRC6;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;UBE2J2;ZNRF2;UBE2D3;MIB1;UBA7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;TSPAN17;UBE2E2;OBI1;UBR4;ASB1;FBXW11;RNF168;RC3H1;RNF167;TRIM59;MYLIP;DTX3;TNFAIP3;BCOR;UBE2M;ERCC8;UBE2L3;PELI2;HERC2;TRIM13;MIB2;RFWD3;KCTD10;RNF10;UBR1;SIAH1;RNF152;AKTIP;RNF2;TRIM3;RNF4;RNFT2;TRIM47;WWP2;HUWE1;FANCL;BRCA1;TRIM28;UBE2R2;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF146;MAEA;RNF38;FBXL22;FBXO17;DTL;TRIM44;ARIH2;RNF122;TRIM45;RNF103-CHMP3;NEURL3;NEURL1B;RNF34;RNF103;TRIM6;RNF114;ASB4;NEURL2;RNF214;TRIM35;RNF31;RNF14;RNF187;ANAPC11
prerank,E-box binding (GO:0070888),-0.4096043622791754,-1.3127181291763008,0.10758377425044091,0.42618095184727933,1.0,9/34,20.11%,ZEB1;MITF;HES1;MAX;TAL1;TCF3;TFAP4;TCF4;PPARG
prerank,actin binding (GO:0003779),-0.30400985482583215,-1.3124225473340587,0.033628318584070796,0.42316868137460806,1.0,38/170,13.34%,UTRN;ABLIM1;MYRIP;SORBS1;LIMA1;ITGB1;FERMT2;NOS3;EPS8;PARVB;PHACTR2;MYH9;PRKCE;PARVA;TMSB4X;MICAL2;LRRK2;SYNE1;SYNE2;EMD;EPS8L2;PDLIM5;ABL1;PHACTR4;MACF1;PTK2;EZR;MYO1F;FXYD5;PDLIM1;SHROOM2;PHACTR1;CEACAM1;SYNPO2;LCP1;TPM1;ACTN4;PDLIM3
prerank,cytokine receptor binding (GO:0005126),-0.33881492534854046,-1.3115852791172142,0.047619047619047616,0.4213138116289491,1.0,16/83,11.75%,KITLG;OSMR;JAK1;SPRED2;CCL25;IL6ST;TGFBR3;IL6R;IL34;TGFB2;SMAD2;LIFR;VEGFC;SOCS2;JAK2;USP15
prerank,metal ion binding (GO:0046872),0.2639003075412169,1.3098377474370304,0.01015228426395939,0.4397460085186443,1.0,111/477,17.25%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;IGFBP3;MMP12;GEM;RYR3;SLC25A13;SPOCK1;RP2;DNER;ASTN2;GNAI1;SYT12;SYT11;TKT;OXSR1;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;STK11;CALM2;MAP2K7;CDH12;SPHK1;GSN;PADI1;TRIM27;NUDT18;RYR2;SRPK1;RPH3A;CDH7;GJB2;ENPP3;STK26;ATP4A;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;HMGCLL1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;HMGCL;SRI;HRC;RASGRP1;IDH3A;MYL2;TPPP;CASQ1;NUDT16;CISD3;BRSK2;SYT3;RCN3;APOE;ACVR1C;NDUFAB1;TESMIN;AASDHPPT;PSPH;CDH22;GALNT3;POSTN;ADAM8;ASAH2;CETN3;PCP4;CABYR;CDH13;EFCAB11;SYT9;MSH2;PGP;DHX36
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.41876657568017456,-1.307658736812065,0.13272727272727272,0.42704533315200116,1.0,7/27,8.42%,ITPR1;CNNM2;SLC12A2;ITPR2;SLC9B2;CNNM4;ATP2A3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5193502775952283,-1.3065344717311724,0.137546468401487,0.4261013056950215,1.0,4/13,7.35%,IL1R1;PDGFD;PTPRJ;ERN1
prerank,amino acid binding (GO:0016597),0.3991521577715474,1.3062341207399009,0.13013698630136986,0.442110497915724,1.0,6/31,8.89%,GLRA3;GRIN2B;DDAH2;GLRA1;GNMT;GRM7
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3745140219108736,-1.30524560136697,0.1070811744386874,0.42572128043625884,1.0,18/49,20.36%,TAB3;EPS15;UIMC1;RNF169;MINDY1;IKBKE;RAD18;BABAM2;RNF168;ZFAND6;TNFAIP3;AGAP3;TAB2;HDAC6;BRCC3;RAD23A;IKBKG;PSMD4
prerank,acylglycerol lipase activity (GO:0047372),-0.5432545767664643,-1.304515292329849,0.16696588868940754,0.42375257394740884,1.0,3/11,14.81%,ABHD2;MGLL;LIPE
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4133793407877221,1.303176386495148,0.13145539906103287,0.4436490336860088,1.0,7/26,12.27%,B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3;EXTL2;CHSY1
prerank,zinc ion binding (GO:0008270),-0.2800433387039257,-1.3000378111243966,0.017006802721088437,0.43024689159799434,1.0,103/293,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;RXRA;PTPN1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;CTCF;TET2;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;ZFYVE1;RC3H1;SLC30A5;TAB2;SKI;KDM5B;RPS27;HDAC10;HPF1;GDA;ZMYND11;ERAP1;SOD1;KDM1B;CZIB;TES;SIAH1;NUDT12;RNF2;NPEPPS;PIAS4;PPARG;BAZ1B;TRIM28;MDM2;BLM;RABIF;CALB1;TET3;APIP;SEC24C;BBOX1;PGGT1B;USP16;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;TIMM10;RABGGTB;QPCTL;ARIH2;CDADC1
prerank,damaged DNA binding (GO:0003684),-0.37655131320531676,-1.2998417401658615,0.13043478260869565,0.42723035579626156,1.0,19/44,26.67%,CREBBP;ERCC2;RBBP8;RAD18;OGG1;RPA3;RPA1;PNKP;XPC;ERCC3;FANCG;RPS3;SDE2;RPA2;DCLRE1B;NTHL1;HMGB1;DCLRE1A;CRY2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5416761130782428,-1.2996994964874842,0.15236427320490367,0.4240502408659372,1.0,2/11,0.63%,ATP10A;ATP8B1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3107629967570968,-1.2984022089469835,0.048903878583473864,0.4238158649648693,1.0,24/134,9.97%,ABCC4;ABCG2;SLC6A6;SLC26A7;SLCO2A1;SLCO1C1;SLC7A1;SLC7A5;SLC26A2;SLCO3A1;SLC16A12;SLC25A32;SLC5A6;SLC19A2;SLC38A5;SLC16A1;SLC25A25;SLC39A8;SLC1A5;SLCO2B1;SLC13A3;SLC35A3;MFSD2A;SLC52A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4633146187582895,1.2927301007045902,0.1561822125813449,0.4606934396924337,1.0,7/17,17.00%,AK9;AK7;AK5;AK3;NME2;CLP1;AK1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5079618840590776,1.2926701339764892,0.15694164989939638,0.45501758702800393,1.0,5/12,16.83%,AKR1C1;DCXR;CBR1;NDUFS7;CRYZL1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5406618150398811,-1.2904922820692482,0.17572463768115942,0.4378575932514111,1.0,5/10,16.18%,ATM;PIK3C2A;PIK3CD;PIK3CB;PIK3R3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5035739094162898,1.2899904343198982,0.16590909090909092,0.4552168122370587,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,CoA-ligase activity (GO:0016405),0.4818086517937675,1.2891625048139583,0.18693693693693694,0.45124567349584116,1.0,3/14,7.59%,ACSS2;ACSBG1;ACSS1
prerank,platelet-derived growth factor binding (GO:0048407),0.5116999876016891,1.2874785415409464,0.17381489841986456,0.44931084766438356,1.0,6/11,15.31%,COL2A1;COL1A1;PDGFA;COL1A2;COL3A1;PDGFRA
prerank,transcription corepressor binding (GO:0001222),-0.41135928815148515,-1.2858200422930977,0.1282051282051282,0.4452716540343487,1.0,8/27,10.52%,ZBTB16;ESR1;NEK6;ZBTB7A;SUZ12;CTBP2;EHMT1;PER3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.48156812974338015,1.2843650011583723,0.17647058823529413,0.450175037078991,1.0,4/14,9.70%,AK9;AK7;AK5;NME2
prerank,protein kinase activator activity (GO:0030295),-0.3493881239966126,-1.2789225955105643,0.10810810810810811,0.4576670529663659,1.0,17/60,14.78%,AFAP1L2;ABI1;FAM20A;IQGAP1;PAK2;DDX3X;GPRC5C;RICTOR;GAS6;STK3;IRGM;RPLP1;RGCC;RPTOR;MTCP1;WNT11;MARK2
prerank,peptidase activator activity (GO:0016504),-0.43348981182760155,-1.2780811017000153,0.14074074074074075,0.4559893091387011,1.0,12/22,35.90%,CAV1;PSME2;VSIR;APH1A;CASP8AP2;PSME1;ADRM1;NLRC4;PCOLCE2;MAL;CLPX;VCP
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4404247309662751,1.277073318784617,0.1600877192982456,0.45984697610523995,1.0,5/20,5.53%,DLG2;AK9;AK7;AK3;AK6
prerank,calcium channel regulator activity (GO:0005246),0.3706068480692297,1.2759658162250724,0.12072892938496584,0.4565457681151846,1.0,11/37,12.78%,NRXN1;GEM;NPY2R;CALM2;CACNB3;CACNG8;NPY;INAFM2;CACNG4;SRI;SGK1
prerank,Notch binding (GO:0005112),-0.43428385857688095,-1.275077132125085,0.15682656826568267,0.4593308367099578,1.0,10/22,21.16%,JAG2;CUL3;AAK1;NOTCH4;GALNT11;TCIM;JAG1;CCN3;KCTD10;DLL4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5238259719969469,-1.2748214794446004,0.19090909090909092,0.4564690237176616,1.0,2/11,3.11%,SGMS1;SGMS2
prerank,death domain binding (GO:0070513),-0.5256921803581858,-1.2715077662708265,0.17192982456140352,0.4607199111431951,1.0,5/11,15.10%,MCL1;IRGM;DAPL1;CRADD;DAP
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35620481570652823,1.2712513894081003,0.10067114093959731,0.4614437227411586,1.0,13/49,11.30%,SYT1;PCLO;SYT5;SYT12;SYT11;RPH3A;CPNE9;PLA2G4E;CPNE1;ANXA8;C2CD5;MCTP2;SYT4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4273383288381042,1.271194208480884,0.13863636363636364,0.4562710642118121,1.0,6/21,10.02%,PDE4B;PDE3B;PDE1B;PDE10A;PDE1A;PDE11A
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3620729631294898,1.2711553695457394,0.12222222222222222,0.45113608896590884,1.0,10/42,8.42%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.3971584407592158,-1.2702099567151317,0.1446886446886447,0.46016620877016895,1.0,14/33,25.97%,ERI3;XRN1;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,carboxypeptidase activity (GO:0004180),0.3798214274439524,1.269871733911823,0.13938053097345132,0.4486339825029265,1.0,9/35,14.22%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.47924898539666816,-1.2696744692563269,0.18806509945750452,0.45809052893765073,1.0,7/15,17.53%,WDFY1;SNX9;SCARB1;PICALM;WDFY3;ZFYVE1;ZFYVE16
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5182236782774402,-1.262178909437182,0.2115732368896926,0.47229058976242283,1.0,4/11,13.80%,AKAP13;IQGAP1;SH3RF1;KSR1
prerank,ATP hydrolysis activity (GO:0140603),-0.3678410346677682,-1.2579922337664848,0.14638447971781304,0.4792510901171677,1.0,18/41,30.65%,DDX3X;RNF213;TOR1B;MYO18A;ABCB10;CHD3;DNA2;RUVBL2;KIF26A;TOR3A;HSP90AA1;HSPA1B;DHX9;ABCG4;KIF14;CHD1L;TDRD9;DDX4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5126494620638098,-1.2578147172601712,0.1841620626151013,0.476073063711797,1.0,6/11,21.60%,DAB2IP;PPEF2;STK38;TCF3;SASH1;ROR2
prerank,potassium channel regulator activity (GO:0015459),0.34720961541040507,1.2575355794372065,0.11738148984198646,0.4694911895616121,1.0,6/49,6.37%,KCNIP4;DPP10;KCNIP1;DPP6;WNK2;WNK3
prerank,phosphatidylglycerol binding (GO:1901611),-0.4967898571058475,-1.2567717397059939,0.1996370235934664,0.4752930876681145,1.0,6/13,24.24%,PITPNC1;PLTP;GSDME;UQCC3;PITPNA;STOML2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5291155746949513,-1.2563637931586815,0.1962457337883959,0.4728834734565484,1.0,5/10,23.27%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5160683002115645,-1.255717865705672,0.18835616438356165,0.47097822665423383,1.0,5/11,23.27%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,neuropeptide receptor binding (GO:0071855),0.4646259645725741,1.2553934360109809,0.1905781584582441,0.46931417246162865,1.0,5/14,23.47%,SHANK1;NPY;NTS;GAL;AGRP
prerank,phosphotyrosine residue binding (GO:0001784),-0.3762656137665168,-1.2546116724078544,0.13414634146341464,0.47048428514689633,1.0,14/37,16.18%,CRK;SHE;LDLRAP1;YES1;PIK3R1;IRS1;ABL1;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5115741470603604,-1.2537751879001706,0.1889483065953654,0.4688467091159605,1.0,6/12,25.01%,CDK13;CDK12;MAPK1;CDK6;CCNK;BRD4
prerank,miRNA binding (GO:0035198),-0.3988902240553367,-1.2520611435357385,0.13859649122807016,0.46924107572467444,1.0,7/30,14.80%,TUT7;PUM1;ZC3H7B;TUT4;AGO2;RC3H1;HNRNPA1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2776169093764911,-1.2515214816090208,0.04194630872483222,0.4671703720256655,1.0,84/254,24.53%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.51114367235094,-1.2513950723237794,0.19148936170212766,0.46431149888823103,1.0,4/11,7.87%,ITPR1;ITPR2;TRPC4;TRPC6
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4098889519748627,1.2496374206635867,0.16849015317286653,0.47711569388095937,1.0,5/22,10.51%,CPSF1;EXOSC9;CPEB1;ELAVL4;CPEB3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4892350718749587,-1.247690620341959,0.2075812274368231,0.4701889776515218,1.0,5/13,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,exopeptidase activity (GO:0008238),0.3411899411790873,1.2461624766143882,0.12527472527472527,0.4793547277239754,1.0,10/50,9.98%,DPP10;DPP6;MME;TRHDE;CPA2;CPE;METAP2;KDM8;DPEP1;JMJD7
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3789936276336587,-1.2454984771953994,0.14728682170542637,0.47219709818821304,1.0,10/35,16.68%,DYRK1A;LYN;YES1;BMX;ABL1;PTK2;FRK;PKDCC;CSK;FYN
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38369760612222925,-1.244975606366906,0.17228464419475656,0.4702512947196562,1.0,11/32,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,semaphorin receptor activity (GO:0017154),-0.504611289599501,-1.2433608138788919,0.20527306967984935,0.47109134972349936,1.0,3/11,8.44%,NRP2;PLXND1;PLXNA4
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2753661102259274,-1.2426249432861671,0.04882154882154882,0.4696905791377375,1.0,87/269,24.53%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;DTX3L;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;STAT2;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;CDK5RAP3;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,cyclic nucleotide binding (GO:0030551),0.41601745217197267,1.2412910516745808,0.17745302713987474,0.48523831577472576,1.0,8/21,19.07%,PDE4B;HCN1;PDE10A;SLC19A1;PDE11A;POPDC2;POPDC3;PDE4D
prerank,amyloid-beta binding (GO:0001540),0.31205521359666955,1.2404628113051703,0.11134903640256959,0.4817861028096122,1.0,14/79,8.83%,GRIA3;NLGN1;GRIN2B;GRIA4;CACNA1B;GRIN2A;APBA2;CACNA1A;ITM2C;GRIA1;SORL1;BACE1;PGRMC1;GRIA2
prerank,lipase activity (GO:0016298),-0.3626292375380612,-1.2387504026745988,0.15917602996254682,0.4758388828423325,1.0,18/43,36.23%,ABHD2;LIPA;MGLL;LPL;LIPE;SMPD2;DAGLB;DDHD2;LCAT;PNPLA8;PNPLA2;LYPLA1;ABHD15;LIPH;SEC23IP;PLBD1;ABHD12;PLB1
prerank,phospholipid transfer activity (GO:0120014),-0.419640333095913,-1.2363514289462685,0.18703703703703703,0.47780870287544835,1.0,3/21,1.27%,PITPNC1;CERT1;PLTP
prerank,carboxylic acid binding (GO:0031406),0.3654755802519228,1.2349881205407642,0.14352941176470588,0.4890868819518845,1.0,10/38,13.88%,GLRA3;GRIN2B;AKR1C1;GLRA1;EPDR1;GNMT;GRM7;MAG;GLUD1;GRIN3A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.48205642618255107,1.232015955209214,0.20941176470588235,0.49068443328332556,1.0,8/13,25.66%,TRMT10B;TRMT10A;TRMT11;FTSJ1;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5039630966076296,-1.22999742205909,0.20433996383363473,0.48953560207048213,1.0,3/11,10.04%,NAA16;NAA80;NAA15
prerank,ephrin receptor binding (GO:0046875),-0.4221202825812307,-1.226773322776316,0.18411552346570398,0.49386878867608924,1.0,7/21,6.21%,ANKS1A;LYN;PTPN1;CRK;CBL;ABL1;CHN1
prerank,symporter activity (GO:0015293),0.5063139047341119,1.2255485928285825,0.22654462242562928,0.49989720992266873,1.0,4/10,9.49%,SLC5A12;SLC4A4;SLC46A2;SLC28A2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4195752716808417,-1.2252557737351815,0.19525547445255476,0.49441783802704514,1.0,14/24,32.78%,DDX3X;LARP1;RPS14;RPL26;SYNCRIP;RPL5;RPS7;CCT5;IGF2BP2;LARP6;UTP23;SHMT1;RPS13;RPL41
prerank,endodeoxyribonuclease activity (GO:0004520),-0.42250235630466987,-1.224938447273492,0.20390070921985815,0.49196545929022134,1.0,10/20,33.33%,MRE11;RBBP8;ENDOV;DNA2;RPS3;EXOG;EXO1;APLF;RAD50;ENDOG
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3163928602120517,1.2228395858389802,0.11835748792270531,0.5011314113198144,1.0,10/73,10.43%,NPSR1;HCRTR1;SORCS1;SORCS3;GPR37;KISS1R;GIPR;TSHR;LGR5;VIPR2
prerank,nuclease activity (GO:0004518),-0.3403026416748185,-1.218989415559557,0.1692573402417962,0.5027446686867986,1.0,20/52,23.04%,RNASE7;SAMHD1;MRE11;N4BP2;RNASE3;XRN2;OGG1;DNA2;RNASE12;PNKP;PLSCR1;PARN;PDE12;N4BP1;WRN;REXO1;EXOG;REXO5;DIS3L2;NTHL1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3347227776840944,1.2171935053400296,0.17865429234338748,0.5090362303692284,1.0,17/49,19.23%,ATP1A2;MPPED2;PPP5C;PLCXD3;DUSP4;SBF1;SMPDL3B;HDHD2;DUSP8;DUSP15;PTPRO;FRA10AC1;PGP;SMPD1;ENPP6;ACP2;APEX1
prerank,regulatory RNA binding (GO:0061980),-0.36410915512735115,-1.2148148430576173,0.18231046931407943,0.5097369364173105,1.0,8/38,14.80%,TUT7;PUM1;ZC3H7B;DICER1;TUT4;AGO2;RC3H1;HNRNPA1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3206650406215308,-1.2146274175776843,0.15076335877862596,0.5069034524649052,1.0,24/72,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;LDLRAP1;PLCB1;KCNQ1;PICALM;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;OSBPL2;PHLDA3;AMER1;TULP3;FZD7;SNX18
prerank,outward rectifier potassium channel activity (GO:0015271),0.5004201598460395,1.2135213791682062,0.23529411764705882,0.5123477783248288,1.0,2/11,2.42%,KCND2;KCNA5
prerank,transition metal ion binding (GO:0046914),-0.2526224810743997,-1.211302622329469,0.04462809917355372,0.5113767968132873,1.0,131/397,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;NOS3;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;XPNPEP3;RXRA;PTPN1;ATOX1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;LOXL3;CTCF;TET2;ABL1;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;AOX1;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;FDX1;KDM3A;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;CYP2R1;ZFYVE1;RC3H1;SLC30A5;XPNPEP1;JMJD6;TAB2;SKI;COX17;KDM5B;RPS27;MGAT2;HDAC10;HPF1;AOC3;GDA;ZMYND11;CCS;ERAP1;SOD1;WRN;KDM1B;LARGE1;CZIB;TES;SIAH1;NUDT12;COA6;RNF2;GALNT1;NPEPPS;B4GALT1;PIAS4;PPARG;GYG1;BAZ1B;ABCE1;TRIM28;DOHH;MDM2;BLM;RABIF;CALB1;TET3;NOS1;APIP;SEC24C;BBOX1;PGGT1B;USP16;PIM1;XYLT2;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;LCN2;TIMM10;RABGGTB;ENDOU;QPCTL;ARIH2;CDADC1
prerank,phosphatase binding (GO:0019902),-0.2984765936053983,-1.2091824302583576,0.12586206896551724,0.5130430134488202,1.0,26/105,12.73%,CTSC;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;CDKN1B;PXN;PIK3R1;DLG1;MAST2;SHOC2;CHCHD3;PTK2;STAT6;CDH5;SMAD2;MAPK1;CNST;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.369825880761951,-1.2083761571308838,0.20257826887661143,0.5118390175399695,1.0,11/33,28.74%,ZNF326;RTRAF;RPRD2;SPTY2D1;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3279015577969579,1.2032759854676103,0.17225950782997762,0.5305314187134521,1.0,11/55,8.91%,SLC24A4;SLC24A2;ATP2B4;ATP2B2;PKD1L2;CACNA1D;SLC8A2;RYR2;TMCO1;TRPM1;PKD1L1
prerank,water transmembrane transporter activity (GO:0005372),0.4875832073067232,1.2031864973281274,0.2437357630979499,0.525542709034436,1.0,2/11,4.58%,PDPN;AQP4
prerank,SUMO binding (GO:0032183),-0.4732668860732301,-1.2031855390446944,0.23415492957746478,0.5213057106252322,1.0,7/13,19.43%,RNF111;UBA2;SERBP1;SIMC1;HERC2;CASP8AP2;RNF4
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.41115979447751,-1.2018191511863436,0.22010398613518198,0.5214500587118082,1.0,7/20,20.73%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,nuclear export signal receptor activity (GO:0005049),-0.48836833381024874,-1.2012862927747867,0.25555555555555554,0.519499268660496,1.0,5/11,17.86%,NUP42;CSE1L;XPO7;XPO4;NUP214
prerank,dynactin binding (GO:0034452),0.461902707710081,1.1994287890855515,0.2301255230125523,0.5290224425976437,1.0,7/12,19.84%,BICD1;BBS4;MAPT;HTT;BICDL1;HOOK3;SNX5
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4866063860561962,1.1979349106243316,0.22641509433962265,0.5277414020299908,1.0,2/11,2.73%,AKR1D1;AKR1C1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.44253834632652334,-1.195173608821387,0.24057450628366248,0.5311069455554727,1.0,5/16,11.23%,PLTP;THBS1;SCARF1;SCARB1;STAB1
prerank,phospholipase inhibitor activity (GO:0004859),-0.5091137439297622,-1.1950598237502648,0.24581005586592178,0.5281170810169459,1.0,4/10,20.02%,ANXA2;ANXA4;ANXA1;ANXA9
prerank,histone deacetylase activity (GO:0004407),-0.42651473576691046,-1.1933051782407462,0.22490706319702602,0.5294314712747444,1.0,10/19,26.60%,MIER1;HDAC1;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;SUDS3;HDAC5
prerank,protein tyrosine kinase activity (GO:0004713),-0.2925412630762571,-1.1929820135490572,0.152014652014652,0.5269929977119069,1.0,21/108,12.16%,FLT1;TEK;IGF1R;TIE1;DYRK1A;ROR1;INSR;LYN;JAK1;KDR;MERTK;EGFR;YES1;BMX;ABL1;PTK2;EPHA4;FLT4;FRK;JAK2;PKDCC
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.48456027231044096,1.186553713058057,0.23214285714285715,0.5492465020458452,1.0,3/11,8.43%,SLC25A23;SLC35B2;SLC19A1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.36706236178924156,-1.182895000967306,0.218018018018018,0.5487715241586595,1.0,13/34,25.25%,FAM20A;IQGAP1;DDX3X;RICTOR;STK3;IRGM;MTCP1;ALS2;IGF2;PARP16;CAB39L;CCNK;CAB39
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4726489644588562,-1.181147124796205,0.26062846580406657,0.5496983938733736,1.0,5/12,23.27%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1
prerank,protein homodimerization activity (GO:0042803),-0.23946255840433955,-1.1807321011083154,0.046052631578947366,0.5474460046563838,1.0,131/589,18.89%,HIP1;ABCG2;DAB2IP;FOXP2;CPQ;RBPMS;ZBTB16;GHR;PECAM1;ZHX3;SRR;EXT1;PKD2;MCL1;MYH9;NOD1;ST6GAL1;XPNPEP3;ATG7;F11R;TBX1;LRRK2;SYNE1;MAP3K5;ZDHHC3;MID1;CAMK2G;TFRC;ZHX2;PIP4K2A;SP1;FZD4;IDH1;ANO1;CEP57;IL6R;HES1;RASIP1;PDE2A;LRP6;SLIT2;TGFB2;GCH1;RABEP1;HPS4;PIP4K2B;RNF40;SPPL3;BNIP3;ECE1;ERN1;ABCB9;SNX9;ABCD3;ZBTB4;RAB11FIP3;TRPC6;S100A16;PDXK;PEX7;ABCB10;TPST2;FLT4;LDB1;AOX1;ST3GAL2;TPD52;STARD3;SMAD4;ADAM10;AKT1;CHMP4B;CHMP4A;MYOM1;FLNA;GSTM2;TPD52L1;FBLN5;SYT6;STK10;TRIM14;TBC1D22A;TMEM266;TMEM192;MTCL1;IRAK1;MGLL;ACTN1;SFPQ;S100A1;CEACAM1;LPL;LRRFIP1;TPM1;ACTN4;CAT;GBP4;CYP2R1;MZF1;ABCB7;GRHL1;TCF3;XPNPEP1;STARD3NL;HIP1R;ACOX1;PRDM9;DARS2;TPR;TERF2;COQ9;DGAT2;HOGA1;SLK;IRAK2;MGAT2;ALS2;TFAP4;ARNT;GBP5;HPGDS;CASQ2;PEX11A;WRN;NRF1;PLN;IKBKG;MKLN1;MTHFD1L;IKBKB;DEFA6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4462780114167675,-1.180312362538781,0.27385159010600707,0.5453020533412606,1.0,5/15,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4588035971313561,1.1800913738022758,0.2826086956521739,0.5596662570397504,1.0,3/12,3.71%,PDE4B;PDE3B;PDE1B
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.4606981416373682,-1.17611263783103,0.25884543761638734,0.5523268538682058,1.0,13/14,53.97%,RDH10;RDH12;ADH1A;RDH11;AKR1A1;DHRS9;DHRS3;RDH16;HSD17B6;SDR9C7;ADH4;ADH7;RDH5
prerank,glucuronosyltransferase activity (GO:0015020),-0.4150228147099534,-1.1743277156638767,0.24080882352941177,0.5535129862030872,1.0,2/19,3.70%,EXT1;CSGALNACT1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4470899004237975,-1.1718083970225566,0.26045627376425856,0.5565671972500124,1.0,7/15,23.81%,SETD3;ASH2L;PRDM9;KMT2C;WDR82;WDR5;RBBP5
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4662486481207953,-1.1701555537531323,0.2558983666061706,0.5577469458336005,1.0,2/12,6.02%,ENTPD1;ENTPD6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.46279551920839446,-1.1694932786601493,0.27162629757785467,0.5562768222048967,1.0,4/13,12.88%,ZGRF1;DICER1;ENDOV;DNA2
prerank,phospholipase binding (GO:0043274),0.4567331576050002,1.16936157113462,0.27705627705627706,0.5802903943623259,1.0,2/13,1.83%,BLNK;DGKQ
prerank,double-stranded RNA binding (GO:0003725),-0.3035501730910973,-1.1635748784209219,0.1956521739130435,0.5677671596732263,1.0,15/70,14.58%,MBNL1;EIF4H;IFIH1;DDX3X;TFRC;MSN;PRKRIP1;DICER1;DDX60;ACTN1;MTDH;STRBP;LRRFIP1;AGO2;RC3H1
prerank,NF-kappaB binding (GO:0051059),-0.3809364108127055,-1.1632340712588627,0.26127819548872183,0.5653439222180647,1.0,9/24,22.61%,GSK3B;HDAC1;NFKBIA;ANXA4;RNF25;MTDH;CDK5RAP3;TAF4B;RELA
prerank,cation channel activity (GO:0005261),0.28806985821551084,1.1617992238515682,0.17772511848341233,0.5939502737861699,1.0,14/94,8.91%,TRPM3;HCN1;SLC24A4;SLC24A2;UNC80;KCNA2;PKD1L2;TMEM63A;CACNA1D;RYR2;TMCO1;CACNA1E;TRPM1;PKD1L1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.45031602250312985,-1.1615953500948506,0.2849162011173184,0.5661704309520895,1.0,5/12,21.38%,SLC6A6;SLC38A5;SLC36A4;SLC1A4;SLC3A2
prerank,lipoprotein particle binding (GO:0071813),-0.4047213659398624,-1.1586908925165067,0.28,0.5701388942824522,1.0,6/20,12.71%,PLTP;THBS1;SCARF1;SCARB1;STAB1;LPL
prerank,nucleotidyltransferase activity (GO:0016779),-0.41098724970512635,-1.1583838212237891,0.2714535901926445,0.5678143257864747,1.0,9/19,22.11%,TUT7;TENT4B;TENT4A;TUT4;REV1;TENT2;CGAS;TERT;MOCS3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3587584462913853,-1.158377101415791,0.26181818181818184,0.5647343378029316,1.0,11/33,28.74%,ZNF326;RTRAF;RPRD2;CDC73;LLPH;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,FMN binding (GO:0010181),-0.46835581503152246,-1.1568401138341056,0.29285714285714287,0.5653091820877544,1.0,6/11,23.94%,NOS3;POR;MTRR;NOS1;PNPO;PPCDC
prerank,ligand-gated calcium channel activity (GO:0099604),0.4007405532280198,1.1566792248587552,0.2618510158013544,0.6013230801574501,1.0,4/19,7.41%,GRIN2B;RYR3;GRIN2A;RYR2
prerank,peptidoglycan binding (GO:0042834),-0.4945808060538596,-1.1562587654939982,0.28496503496503495,0.563678876262948,1.0,7/10,35.99%,NOD1;RNASE7;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4538494723072335,1.1556110055383373,0.27450980392156865,0.5985179533972291,1.0,3/12,8.43%,SLC25A23;SLC35B2;SLC19A1
prerank,mannose binding (GO:0005537),0.44867127995989975,1.1529370036922808,0.2799145299145299,0.599748216805471,1.0,5/12,19.90%,CD207;MBL2;LMAN1;ACR;COLEC11
prerank,neuropeptide hormone activity (GO:0005184),0.38669706996254194,1.1507095127429656,0.27610208816705334,0.5997670311028335,1.0,4/22,10.26%,PNOC;NPY;PENK;CCK
prerank,cAMP binding (GO:0030552),0.4605911830511579,1.1498098691365894,0.303347280334728,0.5969954209192269,1.0,3/11,5.18%,PDE4B;HCN1;PDE10A
prerank,PDZ domain binding (GO:0030165),0.30748466054522317,1.146307372266788,0.20681818181818182,0.6008274946119404,1.0,9/61,4.85%,GRID2;NLGN1;SLC22A4;ATP2B4;ATP2B2;KIDINS220;CXXC4;GRIA1;CXADR
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.36310555137401407,-1.1442879559599806,0.2714285714285714,0.5905935555416726,1.0,3/28,2.64%,DAB2IP;EDA;TRAF5
prerank,adenylate cyclase binding (GO:0008179),0.47190713391744626,1.1424436885860212,0.30837004405286345,0.6053736773529669,1.0,2/10,5.75%,AKAP6;CALM2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4653634367946464,-1.1418786892415949,0.2931654676258993,0.5935238814373578,1.0,6/12,27.04%,PAN3;PARN;CNOT2;TOE1;CNOT8;CNOT1
prerank,phosphatase activator activity (GO:0019211),-0.438217160982335,-1.1406362682015547,0.3021978021978022,0.593824000218213,1.0,7/14,27.45%,PPP2R5A;PHACTR4;FRS2;PPP2R5E;BMP2;PPP2R5D;PPP2R5C
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.43768939950897523,-1.1389919989160637,0.27340823970037453,0.5948539081458272,1.0,7/14,32.92%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1;RPS27L;MAL
prerank,nucleotidase activity (GO:0008252),-0.430861945640176,-1.1355486868031088,0.302158273381295,0.6006840152081258,1.0,8/15,26.79%,NT5C2;NT5E;NT5C1A;BPNT1;NT5C3B;ACP3;NT5DC1;NT5C
prerank,SUMO transferase activity (GO:0019789),-0.4205190951285942,-1.1349409036407472,0.2937956204379562,0.5991659910752644,1.0,7/16,21.28%,RANBP2;NSMCE2;HDAC4;PIAS2;PIAS4;TRIM28;MDM2
prerank,protein kinase C binding (GO:0005080),-0.328856861202474,-1.1319472231954066,0.244122965641953,0.6036293125565326,1.0,9/43,8.02%,GRK5;CAVIN2;PRKD2;ADAM9;PDLIM5;IRS1;ABL1;PARD6G;ADCY4
prerank,ATP binding (GO:0005524),-0.24675077006945656,-1.130619996307797,0.16724137931034483,0.6040052605050444,1.0,57/266,17.01%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;CARS2;STK3;ABL1;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;ABCF2;DARS2;ABCF3;SRPK2;GALK1;CDC42BPB
prerank,nucleosomal DNA binding (GO:0031492),-0.3981098256001162,-1.1265801574939591,0.2862453531598513,0.6113558253301736,1.0,6/21,14.82%,HDAC1;SMARCC1;SMARCE1;SMARCC2;ACTB;H3-3A
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.44502422573275163,-1.1252454795839377,0.2961672473867596,0.6115094896728908,1.0,3/12,11.33%,DDI2;SPPL3;PSEN1
prerank,actinin binding (GO:0042805),-0.39350957063007785,-1.125023335425381,0.287292817679558,0.6089898291442271,1.0,11/21,22.61%,PKD2;PROM1;PDLIM5;NFKB1;CSRP2;SYNPO2;RARA;MAGI1;PPARG;PKD2L1;RELA
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4742636841246607,-1.1245883070375509,0.3333333333333333,0.6071324971747996,1.0,4/10,14.90%,STAMBP;OTUD4;ATXN3;TNFAIP3
prerank,poly(U) RNA binding (GO:0008266),-0.3943775240554629,-1.1226037296612787,0.31099656357388317,0.6094099775892726,1.0,11/20,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;SSB;RBM11;PABPC5;PABPC1L
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.29405057836640675,-1.1206288525649626,0.25207296849087896,0.6110944840560429,1.0,29/78,26.15%,USP9X;CTSC;CASP12;USP24;USP2;CASP8;USP13;CAPN2;CFLAR;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12;GPAA1;CAPN15
prerank,BMP binding (GO:0036122),-0.46408200181520276,-1.1159339297048145,0.323943661971831,0.6202634139409798,1.0,3/11,8.98%,ENG;BMPR2;GREM2
prerank,muscle alpha-actinin binding (GO:0051371),-0.42112677848222396,-1.1139356943657819,0.31309297912713474,0.6223389262490877,1.0,5/15,13.34%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3
prerank,MHC class II protein complex binding (GO:0023026),0.44181471181630416,1.111552572099129,0.3230088495575221,0.6809150496273232,1.0,4/11,9.22%,MS4A1;ATP1B1;CD81;PKM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.40760122463945037,-1.1112055597161836,0.3238434163701068,0.6228221602947086,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.40760122463945037,-1.1112055597161836,0.3238434163701068,0.6228221602947086,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2299911882635336,-1.1068275805081125,0.16,0.630851001801915,1.0,142/431,28.59%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;RAC1;PEX1;RHOJ;DAPK1;MFHAS1;RHOBTB1;TLK2;PRKACB;MARK1;RPS6KA5;ARF3;RND3;RAB7A;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;TLK1;RAB2A;RASL12;UBA2;CARS2;STK3;ABL1;DNM2;MAST2;ATL2;RHOQ;GCH1;PIP4K2B;ABCC6;RAP1A;GBP6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TGM2;TAP2;RAP1B;PDXK;RAB27A;RAB5A;N4BP2;AKT3;PXK;LATS2;RRAS;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;RAB32;ABCF2;DARS2;RERG;ABCF3;SRPK2;GALK1;CDC42BPB;LSG1;GBP5;RAP2A;MTHFD1L;RRAS2;RAP2C;KRAS;NRAS;CDK11B;HSPA14;LIG4;ARL5C;ABCE1;ARHGEF5;BLM;P2RY1;TUBD1;MAP3K6;PMVK;PNPLA8;HSP90AA1;ARL4C;TOP1;PRPS2;TUBE1;HSPA13;MTG2;RALB;PIM1;ARL2;GBP3;RHEB;HSPA1B;NOA1;DHX9;REM1;PEX6;ARF5;ERCC6;DMPK;TRNT1;MKNK1;RAN;RND1;KIF14;TRIP13;RAB38;TUBG2;HNRNPU;RAP2B;RAB22A;ATP1A1;GNL1;RHOT2;PFKL;TGFBR1
prerank,protein kinase inhibitor activity (GO:0004860),-0.3241155301701201,-1.1062486781463166,0.29236499068901306,0.6292258267442569,1.0,10/42,15.03%,PARVA;SPRED2;CDKN1B;NCK1;SH3BP5L;PRKRIP1;TAOK3;RPTOR;SPRY4;GMFB
prerank,semaphorin receptor binding (GO:0030215),-0.3777018394305097,-1.1054284923514919,0.3202846975088968,0.6283632702419837,1.0,12/23,24.83%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A;PLXNB1
prerank,kinase inhibitor activity (GO:0019210),-0.34490881934484996,-1.102249049400181,0.3052064631956912,0.6331551177847637,1.0,9/33,15.03%,PARVA;CDKN1B;NCK1;LRP6;SH3BP5L;PRKRIP1;TAOK3;SPRY4;GMFB
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2766422612022324,-1.100751886907433,0.25693160813308685,0.6338664844401627,1.0,28/91,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;SH3PXD2B;LDLRAP1;PLCB1;KCNQ1;PICALM;WIPI1;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;WDR45B;OSBPL2;PHLDA3;KIF16B;AMER1;TULP3;FZD7;SNX18
prerank,acid-thiol ligase activity (GO:0016878),0.4182391047459081,1.1004819436180433,0.34451901565995524,0.7067014678872264,1.0,3/13,11.78%,ACSS2;ACSS1;AASDH
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4238672885693791,1.100063203060978,0.32045454545454544,0.7019958614504884,1.0,6/14,20.44%,ISCA2;ACO1;NFU1;CIAO3;EXO5;ACO2
prerank,endopeptidase activator activity (GO:0061133),-0.4564748210535861,-1.0997227651844628,0.3493282149712092,0.633385772094561,1.0,5/10,19.70%,PSME2;VSIR;APH1A;PSME1;ADRM1
prerank,hormone activity (GO:0005179),0.29866205086236597,1.0938631333534696,0.3229665071770335,0.7131916771189911,1.0,8/54,12.80%,PNOC;CHGB;NPPC;TRH;NPY;PENK;CCK;METRNL
prerank,cytokine receptor activity (GO:0004896),-0.27986573026690476,-1.09163230159975,0.30689655172413793,0.6508751507088513,1.0,21/83,22.37%,IL1R1;OSMR;GHR;IL17RD;IFNAR1;IL6ST;FZD4;IL6R;CCR9;LIFR;IL4R;IL17RA;IL17RE;IL10RB;CMKLR1;IL20RB;IFNGR2;F3;IL13RA1;IFNAR2;IL3RA
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36398122489479623,-1.0902271012460913,0.3585951940850277,0.6516273467240975,1.0,8/23,22.11%,HIP1;SH3PXD2B;WIPI1;PLEKHA4;HIP1R;WDR45B;PHLDA3;KIF16B
prerank,translation initiation factor activity (GO:0003743),-0.33314046888921617,-1.0899902404686714,0.33090909090909093,0.6491137577833301,1.0,15/36,33.43%,EIF3H;EIF3E;EIF3C;EIF3B;EIF2B2;AGO2;EIF3F;EIF3A;EIF3I;EIF5B;EIF4G3;COPS5;EIF4A2;EIF2B4;EIF2B5
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4372708683142763,-1.0895214811171947,0.3396584440227704,0.647284656818995,1.0,7/12,24.03%,INSR;PIK3R1;IRS1;SOCS2;IGF1;IGF2;ARRB1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.40684592754126914,-1.0888668036265348,0.35793357933579334,0.6459468866717781,1.0,3/15,7.50%,SLC26A7;SLC26A2;SLC39A8
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.24069963760175195,-1.086749186632592,0.22727272727272727,0.6485355305259527,1.0,100/248,30.65%,GNB1;MYH9;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RNF213;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;TOR1B;RHOQ;GCH1;IRGM;RAP1A;GBP6;MYO18A;RAP1B;ABCB10;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;CHD3;RAB8B;RHOA;DNA2;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RUVBL2;RERG;AGAP3;KIF15;RAB11A;KIF26A;LSG1;GBP5;TOR3A;MYL6;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;HSP90AA1;SAR1A;MTG2;RALB;GNB2;KIF18B;ARL2;GBP3;RAB19;RHEB;GNG3;HSPA1B;DHX9;GNGT2;RAB6B;ABCG4;GNA11;RAN;GPN3;RND1;KIF14;RAB38;RAP2B;RAB22A;GNL1;RHOT2;RAB21;RAB18;CHD1L;GNG8;TDRD9;ARL8B;RAP1GAP;RAB31;DDX4
prerank,ribosomal small subunit binding (GO:0043024),-0.40351735550227985,-1.0858210091199234,0.32727272727272727,0.6482705434868199,1.0,4/17,9.11%,EIF4H;DDX3X;LARP1;PTCD3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.30060548949381966,-1.0846715128266256,0.3217550274223035,0.6481940969807882,1.0,12/55,10.66%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC25A32;SLC38A11;SLC19A2;SLC38A5;SLC16A9;SLC16A1;SLC13A3;SLC16A6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.30949666909400747,-1.083976716104389,0.3315696649029982,0.6468515732096187,1.0,9/48,7.87%,SLC12A7;PIEZO2;PKD2;TRPM6;TRPM7;SLC12A2;ABCC9;TRPM4;TRPC6
prerank,G protein-coupled receptor binding (GO:0001664),0.2518995792285122,1.0839673228989706,0.28475336322869954,0.7350584671493596,1.0,25/132,15.82%,GNAO1;BICD1;WNT7B;PACRG;GNAI2;GIP;TAFA5;PSMC5;PNOC;GNAI1;CALCA;GNAL;GNAT3;NPY;HOMER1;PENK;ARR3;WNT6;CCL5;RSPO1;BBS1;NTS;WNT4;GPRASP2;DVL2
prerank,cGMP binding (GO:0030553),-0.44942246336564107,-1.0815671655796875,0.3474264705882353,0.6497728264854506,1.0,2/11,6.05%,RAPGEF2;PDE2A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33436506660856996,-1.080844204535644,0.3505338078291815,0.6486635471102371,1.0,10/33,20.91%,DCUN1D3;RNF125;UBA2;PPARA;RNF144B;DCUN1D2;RPS3;SIAH1;DCUN1D5;FOXL2
prerank,Hsp70 protein binding (GO:0030544),0.33152365059486943,1.0780945622337845,0.3210161662817552,0.7459221745204032,1.0,12/31,20.18%,PACRG;GPR37;DNAJC8;RNF207;METTL21A;PPID;CYP1A1;HIKESHI;DNAJB2;IQCG;DNAJB1;DNAJC18
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3448326523085651,-1.0774323780166846,0.35714285714285715,0.6546966898924035,1.0,12/27,31.13%,SLC26A7;SLC26A2;ANO1;SLC39A8;SLC25A11;SLC26A11;ANKH;SLC5A5;LRRC8A;SLC22A8;SLC26A6;SLC25A10
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.2868231845143473,-1.0773324011458472,0.33513513513513515,0.6520361938014687,1.0,11/69,10.04%,CREBBP;KAT6B;KAT2B;ZDHHC6;PLA2G4A;KAT6A;ZDHHC3;NAA16;CERS4;NMT1;NAA15
prerank,acetylcholine receptor activity (GO:0015464),0.3593744059616983,1.0768633265998249,0.34497816593886466,0.7432080605266059,1.0,2/22,5.19%,CHRM2;CHRM3
prerank,N-acetyltransferase activity (GO:0008080),-0.3853224859822212,-1.075642524302705,0.35071942446043164,0.6534478268971496,1.0,4/19,11.31%,KAT2B;NAA80;SMARCE1;GNPNAT1
prerank,RNA polymerase II complex binding (GO:0000993),-0.338122898427107,-1.0750765287130106,0.3351851851851852,0.6518740790014643,1.0,11/32,28.74%,ZNF326;RTRAF;RPRD2;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;BRD4;HNRNPU;ELP2
prerank,calcium-release channel activity (GO:0015278),-0.3998760739801913,-1.0726079840794596,0.38503649635036497,0.655020632901752,1.0,8/17,26.11%,ITPR1;PKD2;ITPR2;MCOLN1;TRPA1;MCOLN2;TPCN2;TPCN1
prerank,protein phosphatase 2A binding (GO:0051721),-0.3680923482833268,-1.0723452545704761,0.36684303350970016,0.6528451715750332,1.0,6/23,12.97%,DAB2IP;FOXO1;MFHAS1;STRN3;TP53;CTTNBP2NL
prerank,thioesterase binding (GO:0031996),-0.43595755649231416,-1.071654511946286,0.3935018050541516,0.6517805206849494,1.0,2/11,2.64%,RAC1;TRAF5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.37127249289771,-1.0697577189252265,0.35535714285714287,0.6538950692402894,1.0,6/20,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;DGAT2;LCLAT1
prerank,pentosyltransferase activity (GO:0016763),-0.32663754820965174,-1.0681201905245727,0.35154826958105645,0.6551950493385079,1.0,19/36,36.21%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;LARGE1;PARP16;PARP6;PARP9;PNP;TNKS2;UPP1;PARP3;TNKS;LARGE2;LACC1
prerank,solute:anion antiporter activity (GO:0140323),0.3949687787094949,1.067744094067175,0.3755274261603376,0.7634038415663652,1.0,3/14,5.56%,SLC7A11;SLC26A5;SLC4A2
prerank,protein heterodimerization activity (GO:0046982),0.24010725208739314,1.0671620266783801,0.28501228501228504,0.7590609370508767,1.0,34/178,14.40%,TENM4;ATP1A2;TENM1;NPAS3;QTRT2;NPAS1;PHB2;TENM3;ADCY8;RRAGA;BCL2;GABBR2;TENM2;ATP1B1;NAE1;ADD2;HSF1;ADRA2C;NOLC1;PIK3R2;ADRA2A;PDGFA;IL12A;FXR2;PRMT5;BUD23;ADRA1A;ARNT2;SRI;FZD9;MIGA2;BDKRB2;TAF1;PSMF1
prerank,GTP binding (GO:0005525),-0.24690758101430277,-1.0663212681055159,0.30935251798561153,0.6569679592847181,1.0,60/172,28.46%,INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,tubulin binding (GO:0015631),0.22605885793483896,1.065546929324578,0.24821002386634844,0.7574647534765384,1.0,76/295,19.14%,AGBL4;NAV3;TRIM36;KIF21A;SNPH;EML2;PACRG;NEFM;KIF17;APC2;CCDC88A;CDK5;TTLL12;UNC5C;MTUS2;SYBU;KIF26B;RCC2;DNM1;ARHGEF7;MAP2;TERF1;MAP1S;AGBL1;EML5;PAK1;BBS4;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;STMN2;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;TPPP3;GJB6;TTLL5;MAPRE3;TPPP;KIF1C;TUBGCP2;GOLGA2;HDGFL3;RACGAP1;HOOK1;STMN4;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;HTT;PPP1R42;IFT81;KATNA1;CETN3;DLGAP5;KRIT1;NUMA1;MAP1A;KIF22;MAP6;PDCD5;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4;GJA1
prerank,calcium channel inhibitor activity (GO:0019855),-0.44532840566169274,-1.0652629420555346,0.3929203539823009,0.6567877402919129,1.0,2/11,6.40%,ITPR1;MCUB
prerank,NAD+ binding (GO:0070403),-0.42235154898494887,-1.0645894266351241,0.39501779359430605,0.6557384274248446,1.0,3/12,13.46%,ZC3HAV1;SIRT5;SIRT3
prerank,protein tyrosine kinase binding (GO:1990782),-0.28120488191658677,-1.0631959915366558,0.3502722323049002,0.6564319233061179,1.0,33/71,29.08%,ITGB1;PTPN14;BMPR2;DOCK4;PTPN1;CRK;CBL;GAS6;NCK1;CDH5;TJP2;EPHA4;GRB14;TP53;CEACAM1;DUSP3;NEDD9;ELMO2;ANGPT1;NOX4;HYAL2;DUSP22;TOB1;PTPN11;HSP90AA1;CD247;MAP3K7;KHDRBS1;PTPN2;TRIM6;TREM2;ANGPT4;PHYHIP
prerank,guanyl ribonucleotide binding (GO:0032561),-0.24131930002819238,-1.0619570964955394,0.3114754098360656,0.6565689156304649,1.0,67/196,28.46%,RAPGEF2;INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;GNAI3;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;MIEF1;RAB5B;PDE2A;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RAB8B;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;RAB9B;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,chemokine activity (GO:0008009),0.32965411756643115,1.0616415087027948,0.3685446009389671,0.7633103303325423,1.0,7/31,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,GTPase activity (GO:0003924),-0.24014888327761988,-1.0581034563710066,0.32275132275132273,0.6632746752052494,1.0,73/192,28.46%,GNB1;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;RHOQ;GCH1;IRGM;RAP1A;GBP6;RAP1B;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;RAB8B;RHOA;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RERG;AGAP3;RAB11A;LSG1;GBP5;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;SAR1A;MTG2;RALB;GNB2;ARL2;GBP3;RAB19;RHEB;GNG3;GNGT2;RAB6B;GNA11;RAN;GPN3;RND1;RAB38;RAP2B;RAB22A;GNL1;RHOT2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43675083413714344,1.057683539006938,0.4053333333333333,0.7691194855823252,1.0,4/10,23.44%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,Toll-like receptor binding (GO:0035325),-0.42732794628835047,-1.0569138871817654,0.3996282527881041,0.6634834273328537,1.0,1/11,0.25%,DAB2IP
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3860200093197722,1.0549238592872547,0.36619718309859156,0.7712694925214227,1.0,4/15,13.80%,SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,anion transmembrane transporter activity (GO:0008509),-0.426240084720752,-1.053661627702782,0.40304182509505704,0.6688183474029864,1.0,3/12,8.86%,ABCG2;SLC39A8;SLCO2B1
prerank,magnesium ion binding (GO:0000287),-0.2504386625074991,-1.049289192487168,0.33949579831932775,0.6770357806427124,1.0,35/135,21.93%,SNRK;MAP3K20;SRR;PRKACB;MARK1;SIK1;LRRK2;MAP3K5;NEK6;IDH1;UBA2;STK3;ABL1;PDE2A;MAST2;ERN1;CDC42BPA;PDXK;SIK3;ENDOV;STK38;PLSCR1;MARK2;MAPK12;SRPK2;CDC42BPB;HPRT1;HPGDS;RAP2A;WRN;NUDT12;CLYBL;GCLC;MAP3K6;DIS3L2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.40480100989423895,-1.0474149321790924,0.3963963963963964,0.678820252844413,1.0,7/13,26.09%,SLC7A1;SLC38A5;SLC7A7;SLC7A2;SLC66A1;SLC3A1;SLC7A3
prerank,galactosyltransferase activity (GO:0008378),-0.42806509071085774,-1.0455321549520615,0.41869158878504675,0.6809038623730825,1.0,4/11,19.41%,A4GALT;B4GALT4;B4GALT5;B4GALT1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.30908386128918514,1.0396860786948678,0.3795454545454545,0.810100412665805,1.0,5/38,3.95%,MAGI2;GRIP1;BLNK;SHANK1;CD3G
prerank,single-stranded DNA binding (GO:0003697),-0.26064894317612924,-1.0390065294176416,0.3663716814159292,0.6944838885409046,1.0,41/93,32.33%,STN1;RBMS1;DMC1;TOP3A;SAMHD1;POLR2G;NABP1;MCM9;RBBP8;MCM4;RTF1;RPA3;RPA1;CTC1;XPC;HNRNPA1;FUBP1;RAD23A;RPA2;RAD51AP2;BLM;MCM3;TOP1;PCBP1;MSH3;HMGB1;DHX9;POLR2H;MCM7;CRY2;MCM5;MCM10;HNRNPU;RAD51AP1;TDP1;SUB1;RAD51D;MCM2;NUP35;JCHAIN;MEIOB
prerank,retinoic acid binding (GO:0001972),-0.4114680381134349,-1.035986637585672,0.4128787878787879,0.6995408502040846,1.0,3/12,20.86%,RXRA;RARA;NR2F2
prerank,3'-5' exonuclease activity (GO:0008408),-0.3008107668560983,-1.0356536515086257,0.41379310344827586,0.6974423540773689,1.0,15/45,25.97%,ERI3;MRE11;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;WRN;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4286453634347223,1.0353955909644852,0.4132762312633833,0.8167004405734497,1.0,2/10,4.82%,ADARB2;CDA
prerank,RNA stem-loop binding (GO:0035613),-0.4149260763636173,-1.0345281253991676,0.4381625441696113,0.6975719648022182,1.0,5/12,26.87%,DDX3X;RC3H1;METTL16;DHX9;LARP6
prerank,adenyl ribonucleotide binding (GO:0032559),-0.22464084901375184,-1.0340033141014957,0.36203866432337434,0.6960512590928095,1.0,56/291,14.97%,RAPGEF2;SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;MIEF1;CARS2;STK3;ABL1;PDE2A;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;CNBD2;MAP4K4;MARK2;ABCF2
prerank,DNA secondary structure binding (GO:0000217),-0.3232151410778633,-1.0338225770084908,0.4073394495412844,0.6936816192514136,1.0,14/31,30.50%,ABL1;MEF2C;RBBP8;CLSPN;RAD18;XPC;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51AP1;RAD51D
prerank,poly-pyrimidine tract binding (GO:0008187),-0.35081596294505113,-1.0329660271136774,0.4084507042253521,0.6930952756547034,1.0,12/23,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;HNRNPU;SSB;RBM11;PABPC5;PABPC1L
prerank,epidermal growth factor receptor binding (GO:0005154),0.3344831626401976,1.0315274351860833,0.41685144124168516,0.8225215123879839,1.0,4/25,8.96%,ERBB4;CCDC88A;EFEMP1;SHC1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.43285983407337525,-1.0314238696105311,0.4035714285714286,0.6942531277565256,1.0,2/10,4.72%,KAT2B;CDKN1B
prerank,GTPase inhibitor activity (GO:0005095),-0.40788774838819253,-1.0300545628700881,0.3927272727272727,0.6949236269903962,1.0,6/13,24.79%,IQGAP1;SLIT2;PDE6D;RTKN;ARL2;GPS2
prerank,single-stranded RNA binding (GO:0003727),-0.29471547223212435,-1.0298994412614462,0.3996415770609319,0.692517606785679,1.0,11/43,15.54%,EIF4H;IFIH1;DDX3X;POLR2G;DDX60;ENDOV;HNRNPF;STRBP;AGO2;HNRNPA1;JMJD6
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.36137175171982516,-1.0295965335668682,0.40476190476190477,0.6904613835583986,1.0,3/20,1.63%,SENP1;EIF3H;USP9X
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.39001102010247474,1.028256649199321,0.41067285382830626,0.8263524119033113,1.0,4/14,12.71%,SPOCK3;SPOCK1;TIMP1;FETUB
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.41239592370246336,-1.0278023373169598,0.4101633393829401,0.6923048023559303,1.0,3/12,10.05%,DAB2IP;CDH5;VEGFC
prerank,3'-5' DNA helicase activity (GO:0043138),-0.38358695397825754,-1.0276852630452178,0.43501805054151627,0.6898684368607252,1.0,9/16,31.28%,NAV2;ERCC3;FANCM;WRN;BLM;DHX9;MCM7;MCM5;MCM2
prerank,ankyrin binding (GO:0030506),0.35718431370934217,1.0276308898511348,0.4366812227074236,0.8219166715743189,1.0,6/19,11.91%,NRCAM;FLNC;CACNA1D;SCN5A;SPTBN4;SLC8A1
prerank,TBP-class protein binding (GO:0017025),-0.3520006560295361,-1.0252159345780605,0.424408014571949,0.6934756823778861,1.0,6/21,15.76%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2
prerank,microtubule binding (GO:0008017),0.2246912729877021,1.023448284125181,0.3862559241706161,0.8281424961505445,1.0,61/222,19.08%,NAV3;KIF21A;SNPH;EML2;NEFM;KIF17;APC2;CCDC88A;CDK5;MTUS2;SYBU;KIF26B;RCC2;DNM1;MAP2;TERF1;MAP1S;EML5;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;GJB6;MAPRE3;TPPP;KIF1C;TUBGCP2;CLIP4;GOLGA2;HDGFL3;RACGAP1;HOOK1;MAPRE1;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;KATNA1;CETN3;DLGAP5;KRIT1;CAMSAP3;NUMA1;MAP1A;KIF22;MAP6;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2979433982156935,-1.0215180493984852,0.4007029876977153,0.7006527577121356,1.0,24/42,40.60%,KAT2B;CDKN1B;CCND3;CCNY;CCNC;CCND1;CNPPD1;CDKN2C;CCNYL1;CCNG1;CCNK;CCNE2;CCNJ;CDKN2B;CCNH;CCND2;CCNL1;CDK5R1;CCNE1;CCNA2;CKS1B;CDKN1A;CCNB1;CDKN2D
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.28729856389166053,1.020118537931824,0.4135667396061269,0.8318798630207526,1.0,8/46,11.60%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;PIGP;MGAT5B;HEXB;EXTL2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.41903088124529264,1.019467093759873,0.45147679324894513,0.8277831030166211,1.0,10/10,58.12%,USP22;NAA40;BRCA2;EP300;NAA50;KAT8;MSL3;HAT1;ATF2;NAA60
prerank,histone methyltransferase binding (GO:1990226),0.4098235689964925,1.0190281225167703,0.4351648351648352,0.8231599506695736,1.0,8/11,30.77%,NOP56;LCOR;HSP90AB1;LCORL;PRDM4;CBX3;PHF1;WIZ
prerank,ion channel inhibitor activity (GO:0008200),-0.3178395609548699,-1.0179292686641133,0.4343807763401109,0.7068182439525167,1.0,9/35,17.41%,ITPR1;NEDD4L;MCUB;NEDD4;STX8;WNK4;RASA1;SCN3B;KCNMB2
prerank,mannosyltransferase activity (GO:0000030),-0.3476819706963734,-1.0176904038012868,0.4422735346358792,0.7046524076192208,1.0,5/21,12.20%,TMTC1;TMTC2;ALG12;ALG8;PIGV
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3308128599638503,-1.0162941279208357,0.4311594202898551,0.7054415065058228,1.0,8/27,20.91%,DCUN1D3;RNF125;PPARA;RNF144B;DCUN1D2;SIAH1;DCUN1D5;FOXL2
prerank,sterol binding (GO:0032934),0.270595285426421,1.012323251632862,0.4426605504587156,0.8373014645849497,1.0,18/56,21.40%,INSIG1;SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;OSBPL9;GRAMD1B;OSBPL11;GPR183;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,chloride channel regulator activity (GO:0017081),0.3803199254005097,1.0093930978877044,0.4467120181405896,0.839693004968587,1.0,5/14,17.90%,WNK2;WNK3;VTI1B;SGK1;SGK3
prerank,voltage-gated anion channel activity (GO:0008308),0.37425887462865404,1.008657583785498,0.43640350877192985,0.8359125462918434,1.0,7/15,24.68%,CLCNKA;CLCN2;VDAC2;VDAC1;CLCN5;CLCN1;CLCN6
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.42335314052506096,-1.0085455276417565,0.4501779359430605,0.7228033285468949,1.0,8/11,52.63%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,snoRNA binding (GO:0030515),0.3137119807336167,1.0031421236142075,0.4657534246575342,0.8466644710038169,1.0,10/30,25.10%,NOP56;XRCC5;TBL3;NUDT16;TSR1;UTP6;NOP10;ISG20;WDR3;RRP9
prerank,MHC protein binding (GO:0042287),0.3402213783285243,0.999990757075532,0.43680709534368073,0.8500340659888858,1.0,3/20,9.38%,COL2A1;CD81;KIR3DL2
prerank,myosin V binding (GO:0031489),0.3682059859355753,0.9991329142779152,0.45598194130925507,0.8466754712982077,1.0,6/15,21.52%,RAB3C;RAB27B;RAB3A;RAB6A;RAB3B;RAB8A
prerank,glutamate receptor binding (GO:0035254),-0.3654438541750252,-0.9961910029320226,0.44244604316546765,0.7513083734466973,1.0,2/17,0.77%,HIP1;SHANK3
prerank,exoribonuclease activity (GO:0004532),-0.39641486641796,-0.9948365494477253,0.4621212121212121,0.7519982509997801,1.0,6/12,25.27%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EXOSC5;EXOSC7
prerank,chemokine receptor binding (GO:0042379),0.2998134288694678,0.994551994041148,0.45605700712589076,0.8546280819714526,1.0,7/35,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,Tat protein binding (GO:0030957),-0.42159624609750435,-0.9938691347395515,0.46972477064220186,0.7516280389361959,1.0,4/10,30.91%,MDFIC;ACTB;SMARCB1;TRIM32
prerank,kinesin binding (GO:0019894),-0.32023033792890654,-0.9885867149532184,0.43189964157706096,0.7625084409555162,1.0,9/27,23.68%,NEK6;TOR1B;CROCC;ACTB;AP1G1;ARHGEF10;PRC1;SPAG9;KIF18B
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3318361006312075,0.9875423881885914,0.4608294930875576,0.8694949227476584,1.0,3/21,14.36%,GRIK2;P2RX3;P2RX5
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3808040585727628,-0.9872023073735461,0.48428835489833644,0.7633468621573899,1.0,4/14,16.49%,SLC26A7;SLC26A2;SLC25A11;SLC26A11
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.28038884323447033,-0.9853742396768848,0.4810810810810811,0.7653579626320198,1.0,16/47,23.45%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;SLC1A5;SLC25A44;SLC7A7;SLC36A4;SLC43A1;SLC7A2;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,lysine-acetylated histone binding (GO:0070577),-0.3419346475677364,-0.9844910953813074,0.47017543859649125,0.7618803252270638,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,acetylation-dependent protein binding (GO:0140033),-0.3419346475677364,-0.9844910953813074,0.47017543859649125,0.7618803252270638,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,solute:sodium symporter activity (GO:0015370),0.31433059054721224,0.9831977320050319,0.49191685912240185,0.8761380901363656,1.0,5/27,13.97%,SLC34A1;SLC4A4;SLC4A5;SLC28A2;SLC13A5
prerank,cation:chloride symporter activity (GO:0015377),-0.4214350613787594,-0.9809009468855729,0.513986013986014,0.7681831455844799,1.0,2/10,4.55%,SLC12A7;SLC12A2
prerank,chemorepellent activity (GO:0045499),0.3179492486522373,0.9768290009330396,0.4895591647331787,0.8898275357656645,1.0,4/25,5.72%,NRG3;NRG1;SEMA6D;SEMA3B
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2743710066208823,-0.9754438199406863,0.48114901256732495,0.7793290203270248,1.0,20/53,30.32%,NOS3;DLD;MICAL2;AOX1;ACADL;ACADVL;ACOX1;NOX4;ACOX3;AGPS;KDM1B;POR;KMO;MTRR;NOS1;CRY2;PPOX;MICAL1;STEAP4;FOXRED2
prerank,aminopeptidase activity (GO:0004177),0.3118545828198107,0.9740060002055217,0.5066079295154186,0.8924120422000319,1.0,5/26,9.98%,TRHDE;MMP16;METAP2;KDM8;JMJD7
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3560702911191258,-0.9721934448112405,0.47889908256880737,0.7845174662718232,1.0,2/16,2.73%,SLC26A7;SLC26A2
prerank,disordered domain specific binding (GO:0097718),-0.3244964449259591,-0.970974478713797,0.5062388591800356,0.7847373775987342,1.0,6/23,22.46%,RB1;SMAD2;TP53;FYN;MDM2;HSP90AA1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3303364143618128,-0.9658609327640877,0.5159574468085106,0.7951378054171885,1.0,8/22,18.44%,TAB3;UIMC1;RNF169;IKBKE;RNF168;TNFAIP3;TAB2;IKBKG
prerank,nuclear receptor coactivator activity (GO:0030374),-0.27423888207078245,-0.9643527340184835,0.5045537340619308,0.7962378018008286,1.0,14/52,19.92%,TACC1;ZMIZ1;ETS1;MED1;MED13;HELZ2;MED17;FGF2;ACTN1;ACTN4;CARM1;NCOA6;RNF4;SS18
prerank,ribonuclease activity (GO:0004540),-0.26699704029013666,-0.9626081364668394,0.51985559566787,0.7979119595741223,1.0,21/56,26.09%,RNASE7;SAMHD1;KHNYN;ERN1;RNASE3;EXOSC2;EXOSC1;DICER1;EXOSC3;RNASE12;AGO2;N4BP1;EXOSC8;EXOSC5;EXOG;DIS3L2;RCL1;SMG6;ELAC2;EXOSC7;ENDOU
prerank,voltage-gated chloride channel activity (GO:0005247),0.3960150109651499,0.9618073596437269,0.49353448275862066,0.9237993327932966,1.0,2/10,7.68%,CLCNKA;CLCN2
prerank,calcium activated cation channel activity (GO:0005227),0.3419434969924702,0.9596730866791117,0.5034802784222738,0.9243789692658401,1.0,3/17,6.21%,KCNMA1;KCNN2;TMEM63A
prerank,deubiquitinase activity (GO:0101005),-0.24437542894804312,-0.9593690423672224,0.5259515570934256,0.8032926758360311,1.0,27/88,21.02%,USP53;EIF3H;USP9X;USP24;OTULIN;MINDY1;STAMBP;JOSD1;USP2;USP13;OTUD1;USP40;OTUD4;USP15;USP18;ATXN3;TNFAIP3;VCPIP1;USP34;USP10;BRCC3;BAP1;USP7;JOSD2;UCHL1;USP1;EIF3F
prerank,microtubule plus-end binding (GO:0051010),-0.3332735956963851,-0.9585265232170654,0.49910873440285203,0.8025659828228308,1.0,6/20,19.18%,CLIP1;DST;DCTN1;PAFAH1B1;FBXW11;CLIP2
prerank,pyridoxal phosphate binding (GO:0030170),-0.3347429394761078,-0.9567881857130704,0.5080213903743316,0.8041046458555103,1.0,9/20,29.63%,SRR;PDXK;ABAT;ACCS;CTH;PNPO;PSAT1;GLDC;SHMT1
prerank,retinoid binding (GO:0005501),0.3117717702141561,0.9548228488588245,0.5091649694501018,0.9327836680025471,1.0,3/22,11.11%,PTGDS;CYP26B1;ALDH1A2
prerank,protein kinase regulator activity (GO:0019887),-0.2390741938136695,-0.952047324155143,0.5463917525773195,0.813429874171241,1.0,34/95,31.31%,PARVA;GPRC5C;CDKN1B;NCK1;CCND3;SH3BP5L;PRKRIP1;RPLP1;TAOK3;CCNY;RGCC;RPTOR;WNT11;SPRY4;MARK2;GMFB;CCNC;CCND1;CNPPD1;CCNYL1;CCNG1;CCNK;CCNE2;CAB39;APC;CCNJ;DNAJC3;CXCL10;CCNH;WNK1;CCND2;PPP1R1B;CCNL1;CDK5R1
prerank,N-acyltransferase activity (GO:0016410),0.2897779296528104,0.9505150344625772,0.5299145299145299,0.9392580335591343,1.0,7/32,13.72%,CERS6;NAT8;CERS1;PLA2G4E;CERS3;CERS2;SIRT7
prerank,cholesterol transfer activity (GO:0120020),-0.3491155805082297,-0.9502365368784229,0.5140350877192983,0.8155179261868136,1.0,4/16,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,adrenergic receptor binding (GO:0031690),0.34898202648722904,0.9495536566606628,0.5292792792792793,0.9359546552378871,1.0,7/16,20.33%,MAGI2;ADRA2C;ADRA2A;DLG4;ARRDC3;PDE4D;APLP1
prerank,kinase activity (GO:0016301),0.22954321836978434,0.9489167713923861,0.5435294117647059,0.9316962099366202,1.0,23/109,14.78%,DGKK;DGKI;PKMYT1;DGKQ;ITPKA;CDK5;CDKL5;POMK;BCKDK;SPHK1;ETNK1;GK;PIK3C2G;SPHK2;PI4KA;IP6K2;IPPK;CKMT2;CHKA;TAF1;FCSK;CDC7;FN3K
prerank,MHC class I protein binding (GO:0042288),-0.3799369845511634,-0.9486417757939569,0.5053956834532374,0.8169199268282541,1.0,2/13,7.90%,ABCB9;TAP2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3584216184359784,0.9477198610446445,0.5159817351598174,0.9292778189282215,1.0,3/14,9.28%,QDPR;PYCR2;ALDH1L2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.29427437974112053,-0.9456476906460817,0.5344827586206896,0.8216949169284261,1.0,5/31,5.94%,SLC12A7;PKD2;SLC12A2;ABCC9;KCNK5
prerank,phosphoric diester hydrolase activity (GO:0008081),0.28254203748033824,0.9444707939246827,0.5584988962472406,0.9329792136889499,1.0,10/35,12.14%,MPPED2;ENPP2;PLCXD3;SMPD3;SMPDL3B;ENPP3;PDE11A;MPPE1;PLD3;GPLD1
prerank,endopeptidase activity (GO:0004175),-0.20691622064478465,-0.9438248792744044,0.6359143327841845,0.823534019910977,1.0,69/257,24.07%,ADAMTSL3;SENP1;TRABD2B;USP9X;PCSK7;CTSC;ADAMTS2;PSMA2;USP24;DDI2;MMP2;ACE;ADAM9;TASP1;PSEN2;ECE1;RHBDF2;RHBDD3;PSMB4;AFG3L2;PCSK5;USP2;ADAMTS9;CASP8;USP13;ADAM10;ADAMTS4;TPP2;ADAMTS10;ADAMTS5;ADAMTS20;PSEN1;USP40;ADAMTS17;USP15;THSD4;USP18;ADAM33;PDIA3;HGF;PIK3IP1;USP34;CTSZ;PSMB2;USP10;LGMN;PSMB1;PRSS12;PLAT;CTSH;ZMPSTE24;PSMA8;PREP;HTRA3;USP7;UCHL1;USP1;F3;CTSF;MMP11;PSMA7;CASP2;CTSO;USP16;CASP1;THOP1;USP12;ADAMTSL1;ADAMTS7
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2455041680782845,-0.9430795971483259,0.5678571428571428,0.8225724968862775,1.0,36/79,33.54%,RBMS1;HNRNPA0;LARP1;RNF40;RBMS2;PUM1;SECISBP2;CELF1;TP53;SERBP1;LARP4B;PARN;RC3H1;PABPC4L;RPL5;EXOSC8;RNPS1;ANGEL2;RPS7;RBM24;CCT5;CARHSP1;FXR1;IGF2BP2;ZFP36L1;PABPC1;HNRNPU;UTP23;SECISBP2L;BOLL;CPEB4;RPL41;PUM2;PABPC5;PABPC1L;RNF20
prerank,metalloendopeptidase activity (GO:0004222),-0.24518426368176585,-0.9416322627548525,0.5635673624288425,0.8233991127779954,1.0,16/76,12.77%,ADAMTSL3;TRABD2B;ADAMTS2;MMP2;ADAM9;ECE1;AFG3L2;ADAMTS9;ADAM10;ADAMTS4;ADAMTS10;ADAMTS5;ADAMTS20;ADAMTS17;THSD4;ADAM33
prerank,aspartic-type peptidase activity (GO:0070001),-0.4009765851494884,-0.941287879729403,0.5433628318584071,0.8214747720578595,1.0,2/10,11.33%,DDI2;PSEN1
prerank,P-type ion transporter activity (GO:0015662),0.37021062039125874,0.9411811763379949,0.5432900432900433,0.936344579890985,1.0,2/12,2.92%,ATP2B4;ATP2B2
prerank,cysteine-type peptidase activity (GO:0008234),-0.2518954413532536,-0.9394403282205764,0.5565217391304348,0.8233654237136891,1.0,27/73,23.87%,USP9X;CTSC;USP24;OTULIN;ATG4A;USP2;CASP8;USP13;CAPN2;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12
prerank,four-way junction DNA binding (GO:0000400),-0.3441547589639017,-0.9382396429599148,0.5719424460431655,0.823438229003543,1.0,8/17,30.50%,ABL1;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51D
prerank,sodium:proton antiporter activity (GO:0015385),-0.38118699023606906,-0.9366255507056899,0.5424028268551236,0.8244970341591386,1.0,3/11,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.38759845874434706,0.9337416061954239,0.5399568034557235,0.9519797458277395,1.0,3/10,15.37%,DPYSL5;DPEP1;DPYSL2
prerank,phosphate ion binding (GO:0042301),0.3787505500341835,0.9335043300867335,0.5466101694915254,0.9465955023975019,1.0,3/10,10.48%,RPH3A;ADSS2;ADSS1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3625827808172486,-0.9327546121657664,0.5443262411347518,0.8314093374258283,1.0,3/13,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,MAP kinase kinase activity (GO:0004708),0.35098722981491115,0.9321172483370638,0.5244444444444445,0.9447108763738353,1.0,3/15,6.28%,MAPK10;PAK3;MAP2K7
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3000524028598663,0.9309339713235334,0.5545454545454546,0.9426271433313687,1.0,6/25,8.86%,AKR1D1;CYP46A1;AKR1C1;CYP26B1;SQLE;CYP27A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2594345294803514,-0.93020160916756,0.5919854280510018,0.835018436519696,1.0,15/54,18.27%,ACER2;MIER1;HDAC1;SIRT5;TGM2;NADSYN1;NTAN1;ACER3;HDAC4;ASAH1;MIER2;HDAC6;HINT1;HDAC10;MIER3
prerank,chloride channel inhibitor activity (GO:0019869),0.3856241653688562,0.9299192189970688,0.5495495495495496,0.9396903290510332,1.0,3/10,10.78%,WNK2;WNK3;VTI1B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.34624406294437127,-0.9289156624247725,0.5636704119850188,0.8352794079455814,1.0,4/15,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,receptor ligand activity (GO:0048018),0.20022452561959014,0.9267105883550917,0.7041564792176039,0.942913081115773,1.0,33/245,13.39%,NRG3;NRG1;TAFA1;OSGIN1;CLEC11A;WNT7B;FGF6;TAFA5;TAFA2;GDF1;NBL1;CHGB;SEMA6D;SEMA3B;NPPC;NPY;COLEC10;GRN;TIMP1;FGF5;VEGFA;PDGFA;IL12A;CCK;HMGB2;WNT6;LEFTY1;CCL5;GDF11;METRNL;THPO;BDNF;FGF20
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.36859788202463023,-0.9266263323352892,0.5861456483126111,0.838068491807554,1.0,3/12,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,receptor tyrosine kinase binding (GO:0030971),-0.25397082952220973,-0.9249642931684984,0.6153846153846154,0.8395518499255189,1.0,14/56,16.14%,PTPN14;DOCK4;PTPN1;CBL;GAS6;NCK1;PIK3R1;IRS1;GRB14;TP53;DUSP3;ELMO2;GAB2;ANGPT1
prerank,cation transmembrane transporter activity (GO:0008324),-0.26164471928882144,-0.9248745791979689,0.5873015873015873,0.8369549554056825,1.0,14/48,23.45%,SLC6A6;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC1A1;SLC7A2;PKD2L1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2964121223644293,-0.9247380220621184,0.5816135084427767,0.8343941300517663,1.0,10/28,27.98%,DICER1;DBR1;ENDOV;AGO2;EDC3;DROSHA;ELAC2;RPP30;EXO1;POP4
prerank,ADP binding (GO:0043531),-0.3039257421816408,-0.9240672717410167,0.5709156193895871,0.8332166052772629,1.0,4/25,7.78%,MYH9;MIEF1;ERN1;MYO18A
prerank,omega peptidase activity (GO:0008242),0.22927789885338218,0.9235791139292245,0.6235011990407674,0.9462724992220145,1.0,17/89,12.76%,USP29;OTUD7A;ASRGL1;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,wide pore channel activity (GO:0022829),-0.31200857070860144,-0.9223643105952041,0.584070796460177,0.8346448188940698,1.0,2/23,1.33%,GJC1;GJD3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.39279036343569085,-0.9215443562119313,0.5899814471243042,0.8338814076550849,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,gap junction channel activity (GO:0005243),-0.3166719864368803,-0.9212617501066142,0.591726618705036,0.8317451045607617,1.0,2/22,1.33%,GJC1;GJD3
prerank,protease binding (GO:0002020),-0.2294794112827811,-0.920949695542008,0.6196213425129088,0.829648497027536,1.0,24/99,20.64%,VWF;ITGB1;GSK3B;ANXA2;DVL3;ITGA3;RNF139;CFLAR;ADAMTS4;TP53;CRADD;SLC2A13;TIMP3;COMP;FLOT1;TNFAIP3;SERPINC1;SUMO1;RAD23A;ADRM1;ANXA9;PTEN;F3;ITGB3
prerank,telomerase RNA binding (GO:0070034),-0.30988872081495367,-0.9194387046635161,0.5685185185185185,0.8305939587604967,1.0,10/22,29.48%,TENT4B;XRN1;PARN;TEP1;TERT;SMG6;PINX1;NAF1;HNRNPU;GAR1
prerank,GDP binding (GO:0019003),-0.2509209469612319,-0.9192248036757447,0.6284153005464481,0.8284064213805074,1.0,28/63,30.62%,GNAI3;RAB7A;RAB2A;RASL12;MIEF1;RAB5B;RAP1A;RAP1B;RAB27A;RAB5A;RRAS;RAB8B;RERG;RAP2A;RRAS2;RAP2C;KRAS;NRAS;RALB;RHEB;RAB9B;RAN;RAP2B;RAB22A;RAB21;RAB18;ARL8B;RAB31
prerank,mRNA binding (GO:0003729),-0.20312100595750102,-0.9190630963749762,0.6913793103448276,0.826034889099073,1.0,90/249,30.95%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;LARP1;THOC2;RBM5;RPS14;NOVA2;HNRNPR;KHNYN;UPF3B;RNF40;NUP98;SF3B6;RBMS2;SAMD4A;PUM1;HNRNPM;SECISBP2;HNRNPAB;CELF1;SF3B1;RPL26;TP53;SNIP1;SERBP1;LARP4B;PARN;MARF1;AGO2;RBM20;RC3H1;N4BP1;SYNCRIP;PABPC4L;TPR;RPL5;ADARB1;EDC3;FUBP1;RPS3;RBM4B;DCP1A;RNPS1;ANGEL2;PTBP3;TRA2B;RPS7;RBM25;RPL13A;RBM24;MRPL13;EIF3A;RBM15;PCBP1;SRBD1;KHDRBS1;DHX9;CCT5;CARHSP1;FXR1;NCBP3;RPS2;IGF2BP2;ZFP36L1;RBM47;RPS26;HNRNPL;DXO;RBPMS2;NANOS1;LARP6;PABPC1;HNRNPU;HDLBP;TDRD7;UTP23;PPIE;EIF4G3;SHMT1;SRSF6;SSB;RPS13;SECISBP2L;SHFL;BOLL;LUC7L2
prerank,glutathione transferase activity (GO:0004364),-0.3109234779013146,-0.9169918603833686,0.6187175043327556,0.8284964794276028,1.0,12/23,44.43%,GSTT1;GSTT2;GSTM2;HPGDS;GSTK1;ALOX5AP;MGST2;GSTM5;GSTA4;GSTM4;LTC4S;GSTP1
prerank,phospholipase A2 activity (GO:0004623),0.291893778226352,0.9156936992155138,0.5849889624724062,0.9626441366081012,1.0,4/26,10.06%,PLA2G7;PLA2G3;PLA2G4E;PLA2G6
prerank,frizzled binding (GO:0005109),-0.2763537626905124,-0.9108110528475811,0.6074074074074074,0.8405098021553166,1.0,7/34,13.32%,DVL3;ZNRF3;RNF43;LRP6;WNT16;WNT11;MYOC
prerank,ionotropic glutamate receptor binding (GO:0035255),0.37995251781521566,0.9102746580037072,0.6067415730337079,0.9722535187796818,1.0,4/10,16.99%,IGSF11;SHANK1;DLG4;SHANK2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.23435035509898025,0.9091643803812227,0.6275862068965518,0.9694735745953768,1.0,12/74,10.42%,DGKK;DGKI;DGKQ;POMK;SPHK1;ETNK1;PKM;GK;PIK3C2G;SPHK2;PI4KA;IPPK
prerank,ribosome binding (GO:0043022),-0.26136733754947317,-0.9074900899862539,0.6372007366482505,0.8454048815380693,1.0,9/46,16.52%,NAA16;EIF3C;RPSA;NOMO1;NAA15;SERBP1;EEF2;MRPS27;NCLN
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22769124033832314,0.90331928533038,0.6594724220623501,0.9800102389484838,1.0,16/83,12.76%,USP29;OTUD7A;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,LRR domain binding (GO:0030275),0.33869571831874945,0.9030145684717867,0.5878220140515222,0.9752274917649518,1.0,2/14,2.34%,ROBO1;CRX
prerank,ATPase binding (GO:0051117),-0.24366392983959798,-0.9029725980197338,0.670753064798599,0.853326373144587,1.0,16/71,18.24%,CAV1;PKD2;ESR1;EGFR;EZR;CHMP4A;SLC2A13;PTPN3;PSEN1;S100A1;ATXN3;ATP6V1E1;DNAJC10;BBC3;ATP6V0A1;PLN
prerank,alkali metal ion binding (GO:0031420),0.343171840191405,0.9007693152358032,0.6009280742459396,0.9752947127589718,1.0,7/13,24.11%,ATP1A2;ATP4A;IMPA1;ACAT1;ADPRH;CAPN3;TDG
prerank,GABA receptor binding (GO:0050811),-0.3750462789601674,-0.8982815949614471,0.6145648312611013,0.8611788496466206,1.0,5/11,35.28%,TRAK1;GABARAP;ARFGEF2;LHFPL4;GABARAPL2
prerank,manganese ion binding (GO:0030145),0.2502962828718991,0.8973858026034012,0.6458797327394209,0.978650975621169,1.0,13/48,17.95%,MPPED2;B4GALT7;ARG2;MGAT5B;ATP13A2;MPPE1;HMGCL;NUDT16;ADPRM;GALNT3;GALNT2;MGAT1;IMPA1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.25198352673131325,-0.8971952594993711,0.6376306620209059,0.8611068232384665,1.0,15/51,20.90%,SLCO2A1;SLCO1C1;SLC7A5;SLCO3A1;SLC5A6;SLCO2B1;MFSD2A;SLC25A11;SLC35E4;SLC35E3;SLC20A2;ANKH;SLCO4A1;SLC35D1;SLC5A5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3394592229966892,-0.8967785633421711,0.6404886561954625,0.8593287525685174,1.0,2/15,3.63%,SH3PXD2B;PLA2G4A
prerank,snRNA binding (GO:0017069),0.2574970954132333,0.8960867199154013,0.6580645161290323,0.976401970867318,1.0,15/42,22.93%,SF3B3;LSM7;TUT1;SNRPB2;HEXIM1;CCNT1;SNRNP70;SNRPC;SNRPD3;LSM8;PRPF8;LSM4;NCBP2;CDK9;ISG20
prerank,RNA methyltransferase activity (GO:0008173),-0.3168983184268848,-0.8950355950875896,0.6069469835466179,0.8603420817756088,1.0,5/19,20.23%,METTL4;TGS1;TRDMT1;TRMT9B;TRMT12
prerank,leucine zipper domain binding (GO:0043522),-0.3854254574910421,-0.8950223348935756,0.6083788706739527,0.8576424314038128,1.0,3/10,14.04%,ERC1;AATF;ATF4
prerank,general transcription initiation factor binding (GO:0140296),-0.2963328587982436,-0.8934534526900523,0.6090909090909091,0.8584451474066955,1.0,8/25,23.23%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2;RELA;TAF13
prerank,RNA cap binding (GO:0000339),0.3238197426954675,0.8929007514807656,0.6008771929824561,0.9789053397861418,1.0,8/16,25.68%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3;EIF4A1
prerank,copper ion binding (GO:0005507),-0.2601585540617804,-0.8913072208046824,0.6712564543889845,0.8606525998472948,1.0,21/42,37.66%,ATOX1;LOXL3;PAM;TP53;COX17;AOC3;CCS;SOD1;COA6;SUMF1;TYR;ATP7B;IL1A;PARK7;SCO2;CUTC;HEPH;MT3;LACC1;SNCB;AOC2
prerank,proton transmembrane transporter activity (GO:0015078),0.26243928757448776,0.8901869832301136,0.646551724137931,0.9805265545032719,1.0,7/39,15.59%,COX6A2;UQCR10;SLC46A1;ATP6V1B2;UQCRH;COX6A1;SLC4A11
prerank,hexosyltransferase activity (GO:0016758),-0.2185162942729533,-0.8892826667184247,0.6981132075471698,0.8623637436736491,1.0,23/101,21.70%,GBE1;EXT1;TMTC1;GCNT2;A4GALT;TMTC2;CSGALNACT1;MGAT4B;B3GNT2;B4GALT4;ALG12;MFNG;PIGV;B4GALT5;HAS1;GBA2;LARGE1;B4GALT1;POGLUT3;GYG1;OGT;POMT1;CHPF2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3189672108983059,0.8891397239201826,0.6056338028169014,0.9777560730379918,1.0,5/16,18.30%,HAAO;ALOX12;TDO2;ALOX5;BCO2
prerank,serine-type endopeptidase activity (GO:0004252),0.22194544793079365,0.8882224056389426,0.7399527186761229,0.9747389059575738,1.0,12/80,14.68%,C1RL;CELA3A;TYSND1;RHBDL2;RHBDL3;KLK1;KLK6;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,Hsp90 protein binding (GO:0051879),-0.27459064209739115,-0.8877839359423074,0.6559139784946236,0.8630090641054107,1.0,10/33,18.97%,NR3C1;KDR;SLC12A2;PPEF2;ERN1;UNC45B;PTGES3;HDAC6;RPS3;NOD2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.23847630295642155,0.8856148386234889,0.6724890829694323,0.9758477723190154,1.0,13/57,16.64%,COX6A2;UQCR10;NDUFA1;UQCRH;NDUFA10;CYBRD1;NDUFA5;NDUFS8;NDUFB5;NDUFC1;COX6A1;NDUFS7;NDUFB6
prerank,single-stranded DNA helicase activity (GO:0017116),0.31014626365628706,0.8854400794774167,0.6272321428571429,0.9708918825293047,1.0,2/19,4.13%,WRNIP1;HELQ
prerank,sterol transfer activity (GO:0120015),-0.3240750315166929,-0.8849850883585199,0.6281138790035588,0.866357185664676,1.0,4/17,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3569784075292095,-0.8836754672055118,0.625886524822695,0.8665081402654822,1.0,3/12,13.97%,TENT4B;TENT4A;TENT2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3515898074186551,0.8809628105196308,0.6271929824561403,0.9767691466257864,1.0,2/11,14.01%,DCPS;NUDT16
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3478696587901167,0.8804494165696495,0.6523702031602708,0.9725862349240743,1.0,7/12,24.93%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3
prerank,myosin II binding (GO:0045159),0.364202049198471,0.8803064844602024,0.5958429561200924,0.9674885692060168,1.0,3/10,12.34%,STXBP5L;GSN;LLGL1
prerank,phosphatase inhibitor activity (GO:0019212),-0.31284691974255124,-0.8796554317306708,0.6548507462686567,0.8725725968434291,1.0,9/20,32.55%,PPP1R2;SAG;PTN;ARPP19;SET;BOD1L1;STYX;PPP1R1B;BOD1
prerank,growth factor receptor binding (GO:0070851),-0.22507790352531895,-0.8794460892041668,0.7522935779816514,0.8703325425044616,1.0,15/95,14.62%,HIP1;IL1R1;PDGFD;PTPRJ;IL6ST;IL6R;FGF1;ERN1;FGF7;VEGFC;PSEN1;JAK2;FGF2;PLSCR1;GRB2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.35823550185252784,-0.8791997039746068,0.6342342342342342,0.8681404554848209,1.0,2/11,17.22%,PPP1R2;PPP1R1A
prerank,WW domain binding (GO:0050699),0.27953405535692327,0.8790165219239082,0.6853146853146853,0.9654858752972023,1.0,9/26,23.47%,ENAH;TCEAL6;TRAF4;TCEAL3;LITAF;SCNN1A;TCEAL1;WBP11;DAZAP2
prerank,steroid hydroxylase activity (GO:0008395),0.32009199026578566,0.8769202719495284,0.6278026905829597,0.9654102800029994,1.0,3/16,9.78%,CYP46A1;CYP27A1;CYP11B1
prerank,MAP kinase activity (GO:0004707),-0.33436304164025804,-0.8767093070641221,0.6056603773584905,0.870762260817475,1.0,5/14,23.50%,MAPK1;MAPK8;MAPK12;MAPK7;MAPK11
prerank,NAD binding (GO:0051287),-0.2846678551779519,-0.8765713313888321,0.6477064220183486,0.8683454728061949,1.0,5/26,14.53%,ZC3HAV1;SIRT5;BDH2;SIRT3;NUDT6
prerank,phospholipase activity (GO:0004620),-0.23842458727913302,-0.8760329070045118,0.6635160680529301,0.8668039169910038,1.0,26/67,36.75%,PLCB4;PLA2G4A;PLCB3;NAPEPLD;PLCE1;GDPD1;MGLL;LPL;PDIA3;GDPD3;SMPD2;PLA2G12A;DDHD2;PNPLA8;PLA2G4F;LYPLA1;GDE1;LIPH;PLAAT1;SEC23IP;PLCL1;PLCB2;PLBD1;ABHD12;PLB1;PNPLA6
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.29664800828573246,-0.8751636497240899,0.6256781193490054,0.8660353580117935,1.0,9/21,23.44%,WASF2;KCNQ1;EZR;ARFGEF1;ACBD3;WASF1;ARFGEF2;AKAP1;AKAP9
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.34313137196152427,0.8748584997895311,0.6288888888888889,0.9648843040694147,1.0,2/13,3.02%,CCDC88A;RANBP1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3542776184667539,0.872608559863411,0.6048780487804878,0.9648883385496613,1.0,4/10,23.44%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,cardiolipin binding (GO:1901612),0.36937281205512484,0.8713067962431351,0.6117381489841986,0.9627215511975946,1.0,1/10,2.00%,MME
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3574394326677381,0.8699049582783913,0.6314655172413793,0.9609049711365735,1.0,4/10,15.73%,PKP2;CXADR;CD47;SIRPA
prerank,chemokine binding (GO:0019956),-0.2722087174656403,-0.867433240320543,0.6919014084507042,0.8798483973528896,1.0,8/30,24.66%,ITGB1;CCR9;FGF2;ITGA4;ACKR3;ITGB3;ACKR1;HMGB1
prerank,nuclear import signal receptor activity (GO:0061608),-0.32820885952657225,-0.866984471614247,0.6549912434325744,0.8782022937405505,1.0,3/15,14.45%,KPNA4;KPNA3;KPNA1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.32218883618265004,-0.8667060573453181,0.6296296296296297,0.8759862655126969,1.0,5/16,20.54%,SLC1A5;SLC13A3;SLC25A11;SLC1A1;SLC1A4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.33297493645593157,0.8624161133593495,0.6305309734513275,0.9731938839800293,1.0,2/12,8.34%,ARSI;ARSG
prerank,NADPH binding (GO:0070402),0.3333233472085839,0.8613251888434963,0.6371490280777538,0.9706383894618565,1.0,1/13,2.42%,QDPR
prerank,metalloaminopeptidase activity (GO:0070006),0.31454144914192905,0.8605687502402076,0.636568848758465,0.9672816083281494,1.0,2/16,2.37%,TRHDE;MMP16
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.30258635607052625,0.8589769657825989,0.6726057906458798,0.9655889544518191,1.0,4/18,14.06%,HSD17B12;FAR1;ALDH1A2;AKR1B10
prerank,cholesterol binding (GO:0015485),0.23827583743728198,0.8582088011335842,0.7142857142857143,0.9623932783160168,1.0,14/47,21.40%,SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;GRAMD1B;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,iron ion binding (GO:0005506),0.23734721462383376,0.8581978175816656,0.6866952789699571,0.9574732502660898,1.0,12/48,17.17%,MELTF;FBXL5;ALKBH3;DNAJC24;ISCA2;HAAO;TET1;SCD5;NFU1;ALOX5;ALKBH2;SCD
prerank,tropomyosin binding (GO:0005523),-0.31239805623341,-0.8575925602719969,0.6519337016574586,0.8921622893383173,1.0,6/16,27.19%,TMOD3;NEBL;LMOD1;CALD1;SMTNL2;TNNT3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.35266354693207747,0.8563768988440223,0.6236559139784946,0.9514015080410905,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.35266354693207747,0.8563768988440223,0.6236559139784946,0.9514015080410905,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,heme binding (GO:0020037),0.22875565707579687,0.8554354703469307,0.725,0.9485211420145899,1.0,12/65,15.30%,CYP46A1;NR1D1;CYP24A1;CYP26B1;CYP51A1;PGRMC1;CYP27A1;CYP11B1;HCCS;THAP4;EIF2AK1;TDO2
prerank,exonuclease activity (GO:0004527),-0.25008586178988934,-0.852628560842742,0.7090909090909091,0.8994881551226941,1.0,17/46,28.69%,MRE11;EXOSC2;EXOSC1;EXOSC3;XRN2;PDE12;EXOSC8;WRN;REXO1;EXOSC5;EXOG;DCLRE1B;REXO5;EXOSC7;DXO;EXO1;APLF
prerank,poly(A) binding (GO:0008143),-0.2879345070413121,-0.8477629650068884,0.6882882882882883,0.9062447405303248,1.0,6/21,15.39%,RBPMS;RBMS1;DDX3X;RBMS2;ZC3H14;PABPC4L
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.31042794876476076,0.8452160713810289,0.6597701149425287,0.9659054121396355,1.0,2/14,2.80%,KCNA5;KCNJ3
prerank,rRNA binding (GO:0019843),0.24936067365445713,0.8442870858687442,0.7238979118329466,0.9629502033410408,1.0,7/42,10.23%,RPLP0;MTERF4;ANG;MRPL16;ERAL1;PPAN;NOP53
prerank,monocarboxylic acid binding (GO:0033293),0.29221269138351114,0.8409068678021943,0.6947791164658634,0.965401875538948,1.0,2/18,5.87%,AKR1C1;CYP26B1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3003688273654835,0.8404460181608652,0.6722488038277512,0.9615780715175591,1.0,5/17,15.00%,AKR1C1;TECR;DHCR24;DPYD;MECR
prerank,hormone receptor binding (GO:0051427),0.31547053300426375,0.83958805917881,0.6589861751152074,0.9585663815734836,1.0,3/14,10.26%,TYK2;NPPC;CCK
prerank,alpha-actinin binding (GO:0051393),-0.28025992650091613,-0.8361199314272297,0.7051039697542533,0.9260895514897095,1.0,9/24,20.33%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3;RARA;MAGI1;PPARG;PKD2L1
prerank,anion:anion antiporter activity (GO:0015301),0.29279309755610483,0.8355567588481542,0.6617647058823529,0.9623538524989101,1.0,4/17,8.62%,SLC26A5;SLC4A2;SLC19A1;SLC25A4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.26507038770961777,-0.8315532669134484,0.7277676950998185,0.9321908971729348,1.0,5/29,10.75%,SLC26A7;SLC26A2;SLC1A5;SLC13A3;SLC25A11
prerank,kinase activator activity (GO:0019209),-0.2589148585860756,-0.8306453174169498,0.7189655172413794,0.9311987023680913,1.0,6/30,14.78%,GPRC5C;RPLP1;RGCC;RPTOR;WNT11;MARK2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.2825140079608968,0.8302168853358559,0.701098901098901,0.9682491274358654,1.0,7/22,19.05%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2641173217150333,-0.8274422432448204,0.7406749555950266,0.9346116147525405,1.0,13/29,32.79%,ACER2;ACER3;OVGP1;GBA2;HYAL2;ENGASE;GLA;HPSE;ABHD10;HYAL3;LCT;GANAB;NEU3
prerank,CARD domain binding (GO:0050700),-0.32223210389891976,-0.8271890279313661,0.7189189189189189,0.9323654051062559,1.0,5/14,23.27%,NOD1;IRGM;MAVS;NOD2;CASP1
prerank,ion gated channel activity (GO:0022839),-0.27503888211166927,-0.8269103901031298,0.7327433628318584,0.9300546260390945,1.0,6/24,13.29%,TRPM4;ANO1;TTYH2;ANO6;ANO8;TMEM63B
prerank,solute:proton symporter activity (GO:0015295),-0.30300590623165624,-0.8260404699684679,0.7014652014652014,0.9289445861137284,1.0,4/16,13.25%,SLC39A8;SLC17A5;SLC2A13;SLC2A9
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28825574345957955,-0.8227388572230261,0.7109929078014184,0.9323272014497397,1.0,5/20,16.06%,SETD2;SETD3;EHMT1;KMT5A;ANTKMT
prerank,CXCR chemokine receptor binding (GO:0045236),-0.34366889560991754,-0.8191351050977707,0.7099644128113879,0.9360822867584817,1.0,7/11,40.45%,YARS1;CXCL12;CXCL10;CXCL5;ITCH;CXCL1;PPBP
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.33333088064374405,-0.8116597076101965,0.7150635208711433,0.9467184644387892,1.0,1/11,0.16%,LEF1
prerank,serine-type peptidase activity (GO:0008236),0.19661960721569308,0.8100778073432737,0.8948655256723717,1.0,1.0,14/96,14.68%,C1RL;CELA3A;TYSND1;RHBDL2;PRSS57;RHBDL3;KLK1;KLK6;TMPRSS7;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,transferrin receptor binding (GO:1990459),-0.3413506652588319,-0.8061065792491394,0.7155797101449275,0.9538335774290473,1.0,3/10,18.83%,HFE;IKBKG;IKBKB
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3106589365551295,-0.8059505051033232,0.7329749103942652,0.9513540652473849,1.0,8/14,43.45%,NCF2;NOX4;KMO;MICAL1;AIFM1;NCF1;NCF4;DUOX1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22566950449709586,-0.8047479096782877,0.8186714542190305,0.9506497426877963,1.0,16/53,23.45%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC7A7;SLC36A4;SLC43A1;SLC1A1;SLC7A2;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,endopeptidase regulator activity (GO:0061135),-0.23857013928598927,-0.8046132030163219,0.7964285714285714,0.9480701667007516,1.0,11/40,23.75%,CAST;PROS1;PSME2;ITIH2;VSIR;APH1A;TFPI;PSME1;ADRM1;RECK;ITIH3
prerank,pseudouridine synthase activity (GO:0009982),-0.3177022393805957,-0.8040635699426396,0.7387218045112782,0.9462322697319118,1.0,5/13,29.10%,RPUSD4;PUS10;TRUB1;PUSL1;RPUSD2
prerank,potassium:proton antiporter activity (GO:0015386),0.3304882770608857,0.8017802665000009,0.7136363636363636,1.0,1.0,2/10,5.25%,SLC9A7;SLC9A9
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.23548560397655358,0.8015607229919408,0.8247663551401869,1.0,1.0,5/38,12.03%,SPOCK1;TFPI2;SERPIND1;SERPINA2;SERPING1
prerank,motor activity (GO:0003774),0.2133717583956653,0.7987941163478202,0.8492462311557789,1.0,1.0,12/60,15.42%,KIF21A;KIF17;DYNC2H1;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;MYO6;KIF21B
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.26302210660030123,-0.7979876785772061,0.7688073394495413,0.9538578389629033,1.0,9/26,32.55%,PPP1R2;SAG;PPP1R1A;PTN;ARPP19;SET;BOD1L1;PPP1R1B;BOD1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.29260225842720033,0.7975884937376492,0.7534883720930232,1.0,1.0,5/16,12.18%,MTMR2;MTMR10;MTMR11;MTMR7;INPP5F
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3311657227408462,-0.7974992915040581,0.7355516637478109,0.9519887552523992,1.0,5/11,27.47%,KCNQ1;KCNJ8;KCNE4;KCNH2;KCND3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.28144523874559674,-0.7970322640423374,0.7504587155963303,0.9500300972257693,1.0,4/18,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2059204078548793,-0.7952246947902536,0.8818342151675485,0.9504787356458666,1.0,10/82,12.11%,CAST;ANXA2;APP;SPOCK2;PROS1;NGF;ROCK1;BIRC6;ITIH2;TIMP3
prerank,myosin binding (GO:0017022),-0.22349034490818018,-0.7929264233967065,0.8444846292947559,0.9517160759808831,1.0,13/55,17.76%,MYRIP;SHROOM4;TRAK1;SHROOM1;ARFGEF1;RHOA;MYOC;MLPH;RAB11A;KIRREL1;RAB39B;CALD1;GIPC1
prerank,chemoattractant activity (GO:0042056),-0.2577587371619239,-0.7923731202500465,0.8046594982078853,0.9500140241527533,1.0,6/26,15.33%,BMP4;FGF7;VEGFC;FGF2;HGF;MIF
prerank,"DNA binding, bending (GO:0008301)",-0.30124251093219934,-0.792355882024884,0.7706093189964157,0.9473768321416383,1.0,1/14,0.16%,LEF1
prerank,pre-mRNA binding (GO:0036002),0.24766252589211019,0.7851369511468002,0.7928870292887029,1.0,1.0,3/28,5.26%,CELF5;CELF4;CELF2
prerank,poly-purine tract binding (GO:0070717),-0.2542255345349739,-0.7846586739078063,0.7909407665505227,0.9572704614164846,1.0,4/27,7.26%,RBPMS;RBMS1;DDX3X;RBMS2
prerank,microtubule motor activity (GO:0003777),0.21619239089479764,0.7841630621572404,0.8474178403755869,1.0,1.0,10/51,15.42%,KIF21A;KIF17;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;KIF21B
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.25156231735370727,0.7838169760465662,0.7839080459770115,1.0,1.0,4/24,10.33%,CAMK1G;CAMK4;CAMK2B;MYLK3
prerank,hexosaminidase activity (GO:0015929),-0.30999524205598494,-0.7837590951729714,0.7781885397412199,0.9560538157308976,1.0,5/12,32.00%,CEMIP2;HYAL2;HEXA;HYAL3;CEMIP
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3301720141828085,-0.7834658821602563,0.756140350877193,0.9538242374653266,1.0,4/10,25.72%,DSE;GNE;FUOM;GALM
prerank,NADP binding (GO:0050661),-0.24473362601055498,-0.7811452445949494,0.7929203539823009,0.9547680814040317,1.0,7/32,22.04%,NOS3;GMDS;CAT;DHCR7;LBR;MTRR;NOS1
prerank,pyrophosphatase activity (GO:0016462),-0.21920369607811155,-0.780134099972851,0.8561020036429873,0.9537823824986303,1.0,5/50,8.49%,ENTPD1;DDX3X;ENTPD6;ALPL;BNIP2
prerank,methyltransferase activity (GO:0008168),-0.22716523808803962,-0.7791938142633593,0.8403669724770643,0.952537163301413,1.0,20/46,37.20%,METTL4;SUV39H1;EHMT1;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PRMT3;COQ3;METTL27;EEF1AKMT3;DNMT3B;COMTD1;PRMT7;NSUN4;COMT;EEF1AKMT4;GCSH;NNMT
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2333004985745163,-0.7784467636336317,0.8210922787193974,0.9510528054793126,1.0,14/37,29.29%,SLCO2A1;SLCO1C1;SLCO3A1;UQCR11;SLCO2B1;UQCRFS1;UQCRC1;COX10;SLCO4A1;NDUFA4L2;COX5A;SLCO1B1;SLC22A8;COX4I2
prerank,mRNA methyltransferase activity (GO:0008174),-0.3122767599839731,-0.7777255884789805,0.7517985611510791,0.9495281828135979,1.0,8/12,47.62%,METTL14;METTL16;CMTR2;TRMT61A;PCIF1;TRMT10C;NSUN2;RNMT
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.22782132155977708,0.771813701314847,0.8166311300639659,1.0,1.0,8/34,16.64%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.22782132155977708,0.771813701314847,0.8166311300639659,1.0,1.0,8/34,16.64%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.28217750343289305,-0.770949645903277,0.7650085763293311,0.9542942999502473,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.28217750343289305,-0.770949645903277,0.7650085763293311,0.9542942999502473,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,ATPase activator activity (GO:0001671),0.26118538438147565,0.7707477456916163,0.7885057471264367,1.0,1.0,3/20,6.85%,ATP1B1;DNAJB4;DNAJC24
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3172604258015946,-0.7689639857393473,0.773851590106007,0.9547380812577704,1.0,2/12,8.91%,SLC2A1;MFSD4A
prerank,O-acyltransferase activity (GO:0008374),-0.242741322344612,-0.768876889722385,0.8247787610619469,0.9522763113743126,1.0,7/30,21.53%,PLA2G4A;LPCAT1;MBOAT1;DGAT2;LPCAT3;PIGW;LCAT
prerank,sequence-specific mRNA binding (GO:1990825),-0.3284413298290202,-0.7670298420729718,0.7825278810408922,0.9523646322137613,1.0,6/10,35.05%,RBM24;DHX9;LARP6;SSB;SHFL;ETF1
prerank,ribosomal large subunit binding (GO:0043023),-0.31305122641833016,-0.7652658050209821,0.7861271676300579,0.9523601017409018,1.0,4/11,27.52%,LTN1;RBM3;NEMF;NMD3
prerank,glucose transmembrane transporter activity (GO:0005355),0.26715311706881084,0.7641986490524237,0.792147806004619,1.0,1.0,4/17,11.28%,SLC2A4;SLC2A10;SLC2A8;SLC2A5
prerank,phospholipase activator activity (GO:0016004),0.32177344786942563,0.7625538193315682,0.7603485838779956,1.0,1.0,6/10,28.72%,CCL5;ARHGAP6;BTK;PDPK1;STX4;SRC
prerank,alpha-tubulin binding (GO:0043014),-0.23515470203133418,-0.7624007764121008,0.8493647912885662,0.9538443897098514,1.0,15/31,31.31%,SETD2;DIP2B;TTLL7;DNAL1;FYN;HDAC6;WASHC1;TRPV4;ARL4C;EML4;INO80;DLEC1;EFHC2;ARL8B;CDK5R1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.19224233055820125,0.7623201977319852,0.9118942731277533,1.0,1.0,9/85,11.42%,ENPP2;PGLS;CA2;PGAP1;H6PD;PLA2G7;PLA2G4E;PLA2G6;LIPC
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.24381572591347006,-0.7551323571933127,0.8542024013722127,0.9611767538128076,1.0,8/31,21.22%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2
prerank,fatty acid synthase activity (GO:0004312),0.31575926278648414,0.752192791187242,0.7929515418502202,1.0,1.0,2/10,9.17%,ELOVL4;OXSM
prerank,UDP-glycosyltransferase activity (GO:0008194),0.1939036237785547,0.7503847831658036,0.9389978213507625,1.0,1.0,6/70,7.40%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3
prerank,lysophospholipase activity (GO:0004622),-0.2644181076991333,-0.750346930114739,0.8175438596491228,0.9649021511681918,1.0,4/20,13.54%,PLA2G4A;GDPD1;MGLL;GDPD3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3046803265004526,0.7475933033294966,0.7765237020316027,1.0,1.0,1/10,5.24%,SLC6A11
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23746681950778983,-0.7473994066732178,0.8578856152512998,0.9662906433328908,1.0,15/34,36.49%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2;UBE2I;CDC34;UBE2H;UBE2A;UBE2T;UBE2G2;UBE2C
prerank,adenylyltransferase activity (GO:0070566),-0.2613157726273062,-0.7461344532454245,0.8528368794326241,0.9654257008846304,1.0,4/21,13.97%,TENT4B;ABL1;TENT4A;TENT2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.280727889399117,0.7454018159936602,0.804147465437788,1.0,1.0,4/14,9.97%,MTMR2;MTMR10;MTMR11;MTMR7
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.2998043633052634,0.7451209562280993,0.7894736842105263,1.0,1.0,2/11,7.41%,RYR3;RYR2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.2950408035153798,0.7426536649680033,0.827906976744186,1.0,1.0,12/12,70.52%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;OPN3;RHO;GPR88;OPN1MW;OPN1MW3;RRH;GPR52
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.2184032011529142,-0.7399041510118392,0.8663003663003663,0.9709159151881839,1.0,18/40,37.20%,METTL4;PCMTD1;SUV39H1;SETD3;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PEMT;DNMT3B;METTL18;COMTD1;PRMT7;COMT;ICMT;FBL;NNMT
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2756797791760989,0.7384122052638699,0.8064516129032258,1.0,1.0,1/13,1.49%,IDI2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.30662051554773206,0.7366505650763626,0.8237791932059448,1.0,1.0,2/10,11.97%,PKIB;PRKAR1B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2210703226102277,-0.7350149524080756,0.8767361111111112,0.9743299796283207,1.0,9/35,20.62%,FTO;DUS1L;DUS4L;PUS10;MRPL58;TRDMT1;TRMT9B;TRMT12;TRPT1
prerank,fibroblast growth factor binding (GO:0017134),-0.2534722494887244,-0.7337961303236468,0.8504672897196262,0.9732085024338982,1.0,6/21,20.64%,THBS1;CEP57;FGFBP3;API5;FGFR4;ITGB3
prerank,translation elongation factor activity (GO:0003746),-0.2890736012749733,-0.730198650025538,0.8523131672597865,0.9749201200355405,1.0,6/14,26.14%,EEF2;EIF5A;EIF5AL1;GFM2;TUFM;EEF1B2
prerank,inward rectifier potassium channel activity (GO:0005242),0.23272633676636104,0.7266879870251861,0.841648590021692,1.0,1.0,4/24,11.47%,KCNJ3;KCNN2;KCNJ6;KCNN3
prerank,DNA polymerase binding (GO:0070182),-0.2606687673823139,-0.7252708215055753,0.837979094076655,0.9780122082693488,1.0,6/18,24.76%,PTGES3;FANCD2;HSP90AA1;SMG6;HMGB1;FANCI
prerank,ribonuclease P RNA binding (GO:0033204),-0.30606834636473357,-0.7245209888235897,0.8445297504798465,0.9763286045865951,1.0,6/10,49.66%,RPP30;POP4;RPP40;RPP14;RPP25;RPP38
prerank,RNA polymerase binding (GO:0070063),-0.25837072330824307,-0.7239561805146072,0.8461538461538461,0.9744489827289298,1.0,6/18,26.88%,NEDD4;STOM;PKN2;BRCA1;DHX9;PHRF1
prerank,channel activity (GO:0015267),0.20531624775412394,0.7224480768115892,0.9250535331905781,1.0,1.0,3/41,4.58%,PDPN;BCL2;AQP4
prerank,protein phosphatase activator activity (GO:0072542),0.27529044042798534,0.7222699674269513,0.8497757847533632,1.0,1.0,2/13,5.75%,IGFBP3;CALM2
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.30321960108661017,-0.717574825782477,0.8457627118644068,0.9789282045893184,1.0,5/10,34.76%,HADHB;ECHS1;EHHADH;ECI1;ECHDC3
prerank,DNA replication origin binding (GO:0003688),0.23744420383751225,0.713473397069338,0.875,1.0,1.0,4/23,10.09%,DDX11;MCM8;CDC45;POLA1
prerank,gated channel activity (GO:0022836),-0.271494907945211,-0.7108686236517431,0.8568872987477638,0.9835160187265338,1.0,3/14,13.29%,PIEZO2;TMEM266;TMEM63B
prerank,telomeric DNA binding (GO:0042162),-0.2187207162791863,-0.7104627425259437,0.8979963570127505,0.9813660927635979,1.0,12/32,27.95%,STN1;UPF2;HMBOX1;RPA1;CTC1;TERF2;WRN;TERT;BLM;SMG6;HNRNPD;SMG1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2942715962938125,-0.7102900333824235,0.866785079928952,0.9790046302912666,1.0,5/11,32.12%,SLC17A5;SLC2A9;SLC5A3;SLC23A1;SLC23A2
prerank,endonuclease activity (GO:0004519),-0.20152681324554222,-0.7044730434298715,0.9386281588447654,0.9824200858385783,1.0,14/49,26.09%,KHNYN;ERN1;MRE11;N4BP2;DICER1;OGG1;PNKP;AGO2;RPS3;EXOG;RCL1;NTHL1;SMG6;ENDOU
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.25852968746154614,0.7041798141591582,0.8831168831168831,1.0,1.0,2/15,8.89%,PLA2G3;PLA2G4E
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.22209691278377056,0.701691576129585,0.9160997732426304,1.0,1.0,5/28,12.78%,MAPK10;PAK3;MAP2K7;RPS6KB1;SGK1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.22149531249659332,0.7015737036171678,0.9101382488479263,1.0,1.0,7/27,16.03%,SLC9A7;SLC9A9;SLC8A2;SLC8A3;SLC8A1;SLC4A11;SLC8B1
prerank,methylation-dependent protein binding (GO:0140034),-0.19472886417903187,-0.6976058076551835,0.9491228070175438,0.9865166738866179,1.0,21/57,34.43%,CHD1;KMT2E;CDYL;SUZ12;SGF29;ZMYND8;TDRD3;KDM7A;ZMYND11;ATRX;WDR5;RBBP5;MBTD1;GLYR1;PHF19;CHD8;ING5;KDM4A;CBX5;BPTF;MORC3
prerank,peptidase inhibitor activity (GO:0030414),-0.22032437402824429,-0.6974498863447586,0.8987341772151899,0.9841092066174708,1.0,9/33,26.55%,CAST;PROS1;ITIH2;SIMC1;TFPI;GPC3;RECK;ITIH3;PCSK1N
prerank,FAD binding (GO:0071949),-0.23477119344895586,-0.6939523436454129,0.8898756660746003,0.984808756736091,1.0,11/24,37.66%,MICAL2;AGPS;KDM1B;KMO;MTRR;CRY2;MICAL1;STEAP4;AIFM1;NQO2;DAO
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2173614926097601,0.6873230495794034,0.9045454545454545,1.0,1.0,5/29,11.97%,YWHAG;PKIB;SPRED1;HEXIM1;PRKAR1B
prerank,MAP kinase phosphatase activity (GO:0033549),0.27394462748292286,0.6870642938626086,0.8424507658643327,1.0,1.0,3/12,16.11%,DUSP4;DUSP8;DUSP7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2257699950719702,0.685583720196955,0.9154013015184381,1.0,1.0,4/22,14.69%,SYT1;CLU;APOE;LANCL1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.27348945371667993,-0.6789520237817872,0.8842676311030742,0.9954411941837525,1.0,2/12,13.57%,TRAF5;BABAM2
prerank,titin binding (GO:0031432),0.26334890068281647,0.6745893811500762,0.8955223880597015,1.0,1.0,5/13,27.73%,CALM2;MYBPC1;CAPN3;CALM1;CALM3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.20999041911749766,-0.674531889681907,0.9362101313320825,0.9964595545947145,1.0,10/32,23.32%,KDM2A;TET2;FTO;RIOX2;KDM7A;TMLHE;TET3;ALKBH5;BBOX1;ALKBH4
prerank,N-methyltransferase activity (GO:0008170),-0.23392114961597288,-0.6741294533795609,0.9065255731922398,0.9942251621871266,1.0,8/20,31.50%,SETD3;ZCCHC4;N6AMT1;METTL5;TRMT1;METTL15;PEMT;METTL18
prerank,hydro-lyase activity (GO:0016836),-0.2036089708114515,-0.6739846430075705,0.9442446043165468,0.9918147514587259,1.0,4/41,4.79%,HADHB;GMDS;CA4;CDYL
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2688949456150069,-0.6717806881084434,0.8837638376383764,0.9910934996285239,1.0,5/12,25.45%,PIK3R1;IRS1;GAB2;FRS2;SH2B2
prerank,methylated histone binding (GO:0035064),0.1774407203112857,0.6693892416733483,0.9812646370023419,1.0,1.0,14/62,18.54%,ZCWPW1;CHD5;TTLL12;UHRF1;KDM8;JMJD7;THAP7;CXXC1;TAF1;PHF13;L3MBTL2;CBX8;MORC4;ING1
prerank,carboxy-lyase activity (GO:0016831),-0.22342622224724923,-0.6691508562535975,0.9208261617900172,0.990598556044066,1.0,7/23,25.96%,CSAD;BCKDHA;AZIN1;DDC;PPCDC;MVD;FAHD1
prerank,protein phosphatase regulator activity (GO:0019888),0.18110658969463056,0.668919500295684,0.9742388758782201,1.0,1.0,7/53,10.09%,PPP2R2B;PPP1R7;PPP2R2C;CALM2;PPME1;RCAN2;PPP1R16A
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.27416509328623273,-0.6669866287622235,0.8911819887429644,0.9897952017354081,1.0,4/12,22.61%,HDAC1;H3-3A;RUVBL2;RELA
prerank,tRNA binding (GO:0000049),0.1894802464289938,0.6649394288748821,0.9574944071588367,1.0,1.0,10/43,20.88%,TRMT10B;SARS2;PTCD1;TRMT10A;CARS1;EEF1A1;PUS1;AARS2;ELP1;NSUN6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.1699044423457344,0.6639612887841698,0.9888392857142857,1.0,1.0,12/75,16.79%,AKR1C1;DCXR;H6PD;HSD17B7;NSDHL;CBR1;LDHB;UGDH;AKR1B10;PHGDH;PGD;MDH1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22446623820215117,0.6634641107036522,0.9247787610619469,1.0,1.0,6/22,16.11%,DUSP4;MTMR2;SBF1;DUSP8;DUSP15;DUSP7
prerank,cAMP response element binding (GO:0035497),-0.28230143364424515,-0.6616417299791163,0.8705440900562852,0.9915821809959235,1.0,2/10,7.60%,CREB3L2;JUN
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.27052579293584683,-0.6598254463106333,0.9100719424460432,0.9904185666393096,1.0,3/12,14.75%,AOX1;FDX1;ISCA1
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.22733246114947497,-0.6580110814073642,0.9340659340659341,0.9867814492161056,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.22733246114947497,-0.6580110814073642,0.9340659340659341,0.9867814492161056,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,beta-tubulin binding (GO:0048487),0.20109513340925786,0.6579122067493387,0.9445676274944568,1.0,1.0,6/31,15.61%,PACRG;MAP1S;BBS4;GJB6;RACGAP1;HTT
prerank,deoxyribonuclease activity (GO:0004536),0.24804749636254148,0.6577006366105775,0.9012605042016807,1.0,1.0,6/14,25.72%,MAP1S;DNASE1L1;APEX1;ERCC5;DNASE1L2;ZRANB3
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2537481546210477,-0.6564271299964047,0.9186691312384473,0.9854740832744355,1.0,9/14,49.66%,TSEN34;ELAC2;RPP30;POP4;RPP40;RPP14;RPP25;TSEN2;RPP38
prerank,U6 snRNA binding (GO:0017070),0.2411924347193487,0.6554284768675728,0.888402625820569,1.0,1.0,5/14,20.62%,LSM7;TUT1;LSM8;PRPF8;LSM4
prerank,microtubule minus-end binding (GO:0051011),-0.2552376826064755,-0.6542596072540741,0.8824593128390597,0.9845068475653257,1.0,3/13,16.89%,MACF1;TUBGCP4;TUBGCP5
prerank,sulfotransferase activity (GO:0008146),-0.20237857259613404,-0.6530287585111572,0.9683426443202979,0.9828734089085608,1.0,8/33,20.64%,CHST15;TPST2;CHST11;SULT1A1;HS3ST1;GAL3ST2;HS6ST1;CHST7
prerank,ribonuclease P activity (GO:0004526),0.2610633356349257,0.6521616856236347,0.9010526315789473,1.0,1.0,11/11,73.91%,PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;POP4;RPP30
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22153917102439355,0.6496108416365616,0.9252747252747253,1.0,1.0,4/21,17.54%,FGF6;FGF5;FGF20;FGF22
prerank,cytokine activity (GO:0005125),0.1512863480112406,0.6483526199406712,0.9977272727272727,1.0,1.0,17/131,14.71%,NRG1;WNT7B;CXCL16;GDF1;CCL28;PF4;TIMP1;VEGFA;IL12A;CCL13;WNT6;LEFTY1;CCL5;GDF11;CCL2;WNT4;CCL7
prerank,purinergic nucleotide receptor activity (GO:0001614),0.23774453583778454,0.6442517718988138,0.934640522875817,1.0,1.0,3/15,19.03%,P2RX3;P2RX5;PTAFR
prerank,lipase activator activity (GO:0060229),0.27040148660484603,0.6429185654561984,0.9019607843137255,1.0,1.0,4/10,22.17%,CCL5;ARHGAP6;BTK;PDPK1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.25837561462186753,-0.639742906733051,0.9121863799283154,0.9894653004185648,1.0,1/12,0.70%,PIEZO2
prerank,tRNA methyltransferase activity (GO:0008175),0.23848654189537805,0.637800896730742,0.931924882629108,1.0,1.0,7/16,25.66%,TRMT13;FTSJ1;METTL2A;METTL2B;TRMT5;THUMPD3;THUMPD2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21032460396489602,-0.635814502957533,0.9514388489208633,0.989391053914355,1.0,9/24,33.98%,ZDHHC6;ZDHHC3;ZDHHC1;ZDHHC4;GLUL;ZDHHC12;GOLGA7B;ZDHHC9;ZDHHC22
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.24743888564590152,0.6252499915040498,0.9118942731277533,1.0,1.0,2/11,13.32%,PFN1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),0.24743888564590152,0.6252499915040498,0.9118942731277533,1.0,1.0,2/11,13.32%,PFN1;BAG1
prerank,ubiquitin binding (GO:0043130),-0.16607957880423266,-0.6240173736168955,0.9908925318761385,0.9937791312702966,1.0,20/73,26.90%,DDI2;RAE1;NEDD4;USP13;RNF168;VPS36;TNFAIP3;N4BP1;ILRUN;UBXN11;RAD23A;IKBKG;ADRM1;UCHL1;MDM2;BUB3;USP16;UBXN7;UBXN2A;ASCC2
prerank,endoribonuclease activity (GO:0004521),-0.19392978360179325,-0.6196536783584431,0.9747747747747748,0.9937297360979724,1.0,9/32,26.09%,KHNYN;ERN1;DICER1;ENDOV;AGO2;EXOG;RCL1;SMG6;ENDOU
prerank,lipoprotein particle receptor binding (GO:0070325),0.19447233084107005,0.6168444552873595,0.9846153846153847,1.0,1.0,1/27,0.51%,SYT1
prerank,antiporter activity (GO:0015297),-0.2174084393738801,-0.6157085582987795,0.9466192170818505,0.9933060907367647,1.0,6/20,31.13%,SLC25A11;SLC35E4;SLC35E3;SLC35D1;SLC35C1;SLC25A10
prerank,hyaluronic acid binding (GO:0005540),-0.26093931542813265,-0.6129534377043758,0.933206106870229,0.9922421880031271,1.0,5/10,32.00%,LAYN;HYAL2;LYVE1;IMPG2;CEMIP
prerank,ATPase regulator activity (GO:0060590),-0.18376999975344857,-0.6095675558677641,0.9683098591549296,0.9915052100206178,1.0,8/38,18.89%,DNAJC1;DNAJA2;DNAJB6;FNIP2;DNAJC10;SIL1;PLN;DNAJC19
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.23191863385233552,-0.6046620107852686,0.927689594356261,0.9914003298609879,1.0,14/14,76.83%,CAPN2;CAPN15;CAPN11;CAPN12;CAPN10;CAPN8;CAPNS2;CAPN9;CAPN6;CAPN1;CAPN13;CAPN5;CAPNS1;CAPN3
prerank,chemokine receptor activity (GO:0004950),-0.20222287916526116,-0.6007228931480656,0.970856102003643,0.990754361591793,1.0,10/24,43.40%,CCR9;ACKR3;CMKLR1;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;CXCR5
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.2507795434965753,-0.5932903923159628,0.9371633752244165,0.9915913214910923,1.0,2/10,16.83%,NCF2;NOX4
prerank,receptor antagonist activity (GO:0048019),0.21203330480775207,0.5891152873179081,0.9535398230088495,1.0,1.0,16/17,61.82%,CCL5;ESR2;DKK3;DKK4;IL18BP;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;LRPAP1;AGTR2;FST;WFIKKN1;PXDN;IGSF1
prerank,ferrous iron binding (GO:0008198),0.19460492888855685,0.5853553470328857,0.9650655021834061,1.0,1.0,3/21,10.02%,ALKBH3;DNAJC24;HAAO
prerank,carbohydrate kinase activity (GO:0019200),-0.23610875530376224,-0.5794146828723571,0.9434628975265018,0.9946438524730848,1.0,3/11,16.63%,GALK2;GNE;GALK1
prerank,O-methyltransferase activity (GO:0008171),-0.24286320666824818,-0.5718096094461886,0.9486725663716814,0.994844943864907,1.0,3/10,35.97%,CMTR2;COQ3;COMT
prerank,potassium ion leak channel activity (GO:0022841),0.20986859323216772,0.5706637820018358,0.9638009049773756,1.0,1.0,4/15,21.98%,KCNK12;KCNK10;KCNK9;KCNK4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.21573267197664914,-0.5655333708294695,0.9797794117647058,0.9945218991794725,1.0,5/15,39.52%,CCR9;CMKLR1;GPR17;CCRL2;CCR1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.18213200546555708,-0.5594736037199026,0.9825174825174825,0.9938155653460787,1.0,11/27,34.32%,POLR2G;TENT2;POLR3F;TERT;MED20;POLR2C;POLR2L;POLR3K;POLR1H;POLR2E;POLR3A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.21230036750989448,0.547267418327827,0.9674620390455532,1.0,1.0,2/13,11.11%,ALDH1L2;ALDH1A2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.2307437590291122,-0.5461833400149869,0.9621212121212122,0.9949769947481087,1.0,3/10,27.65%,DCLRE1B;DCLRE1A;EXO1
prerank,palmitoyltransferase activity (GO:0016409),0.17129671943000266,0.544131270111881,0.9841986455981941,1.0,1.0,6/28,16.68%,ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7;YKT6
prerank,CoA hydrolase activity (GO:0016289),-0.19806265768069087,-0.5355162968943599,0.9744525547445255,0.9952461937622997,1.0,10/16,48.63%,ACOT9;ACOT6;ACOT11;NUDT7;ACOT13;HIBCH;ACOT12;ABCD1;BAAT;ACOT4
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.19796711454570765,0.5299409109991193,0.9810526315789474,1.0,1.0,2/15,11.11%,ALDH1L2;ALDH1A2
prerank,leak channel activity (GO:0022840),0.18272159083085102,0.525878245830033,0.982532751091703,1.0,1.0,5/18,21.98%,KCNK12;KCNK10;KCNK9;NALCN;KCNK4
prerank,cytochrome-c oxidase activity (GO:0004129),0.19514107667891228,0.5211824638427576,0.9809725158562368,1.0,1.0,2/15,14.80%,COX6A2;COX6A1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.1800080543669329,0.5018487849125257,0.9866962305986696,1.0,1.0,3/17,13.51%,PLA2G6;ACOT2;ACOT7
prerank,ubiquitin-specific protease binding (GO:1990381),0.16799598065691124,0.4872444489711527,0.9933774834437086,1.0,1.0,19/19,83.22%,LCOR;SELENOS;RHBDD2;DERL2;AMFR;BAG6;SYVN1;SART3;PRKN;SPATA2;DERL3;DERL1;CLTC;VCP;PARK7;CHMP3;PTEN;RAD23A;SUMO1
prerank,gamma-tubulin binding (GO:0043015),0.16129158461021412,0.48161503801744965,0.9977426636568849,1.0,1.0,5/21,18.59%,ARHGEF7;PAK1;TUBGCP2;RACGAP1;CDK5RAP2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.16135903026505002,0.47632269386350323,1.0,1.0,1.0,3/21,14.05%,POLD4;POLA1;POLE4
prerank,C-C chemokine receptor activity (GO:0016493),-0.1633846719328776,-0.4703295244618723,0.9944649446494465,1.0,1.0,9/21,46.47%,CCR9;ACKR3;GPR75;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,C-C chemokine binding (GO:0019957),-0.1571280764940571,-0.46156740579797384,0.9982078853046595,1.0,1.0,9/22,46.47%,CCR9;ACKR3;ACKR1;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.1822861088443914,0.4541201391473323,0.9913978494623656,1.0,1.0,11/11,81.78%,HMCES;APEX1;HMGA2;NEIL2;APEX2;NEIL1;NEIL3;ALKBH1;APLF;NTHL1;RPS3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.1432053252297435,0.44712608487743,1.0,1.0,1.0,5/27,17.89%,POLR3H;POLR2D;POLR1A;POLRMT;POLR1B
prerank,CCR chemokine receptor binding (GO:0048020),-0.1441581933376827,-0.43891748375321493,1.0,1.0,1.0,2/28,9.05%,CCL25;NES
prerank,DNA polymerase activity (GO:0034061),0.14118760487252693,0.42498290328928795,1.0,0.9985268755389479,1.0,3/22,14.05%,POLD4;POLA1;POLE4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.13986556987798404,-0.36852709527502003,1.0,0.9998181100070678,1.0,1/16,4.68%,CD38
